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ABSTRACT 
Cervical cancer (CC) is one of the most common cancers in the world, considered to be 
a direct result from infection with the Human papillomavirus (HPV). Other possible 
contributing factors towards CC include multiple sexual partners, having sexual activity 
from a very early age and immunodeficiency. In 2014, it was concluded that 19 098 
women in South Africa died as a result of CC. Another report noted that CC is the most 
common form of cancer amongst black South African women, particularly those over the 
age of 35 years. Rubus idaeus (commonly referred to as red raspberry), is a plant used 
most commonly to treat disorders of the female genital tract. It is said to possess high 
antioxidant properties and has shown many cytotoxic properties in cases of cancer in 
recent studies. Low level laser therapy (LLLT) makes use of specific wavelengths and 
fluence to repair damaged tissue. Some in vivo studies done previously suggest that LLLT 
has the ability to induce apoptosis in cancer cells. No research demonstrating the 
relationship between Rubus idaeus (R. idaeus) and LLLT on CC has been conducted to 
date.  
The aim of this study was to compare the in vitro effects of R. idaeus (Homeopathic 
mother tincture, D6 and 30cH) and LLLT on CC cell lines.   
This quantitative in vitro research study took place at the Laser Research Centre of the 
University of Johannesburg. This study made use of HeLa cells (ATCC ccl-2) and R. 
idaeus (D3, D6 and 30 cH Homeopathic preparations) and LLLT at 680 nm at 5, 10 and 
15 J/cm2 doses. A HeLa cell culture (ATCC CCL-2) was cultured in Dulbecco’s Modified 
Eagle Medium and sub-cultured from 75 cm2 flasks into 3.3 cm diameter culture plates 
for experimentation. There were three cell groups in this study with each experiment 
repeated a total of 3 times in duplicate. Each of the three experimental cell groups were 
divided as follows; untreated control cells (CC cells not exposed to R. idaeus or LLLT), 
CC cells treated with R. idaeus (D3, D6 and 30cH), CC cells treated with a combination 
of the optimal performing potency of R. idaeus and LLLT at 680 nm diode lasers with 
three fluencies of 5, 10 and 15 J/cm2. The effectiveness of these treatments were 
measured as follows; cell-viability was measured by using Trypan Blue assay, 
morphology by inverted light microscope and cytotoxicity was measured by observing the 
different levels of Lactate Dehydrogenase (LDH) present in the culture medium. 
Apoptosis of the HeLa cell culture was analyzed via Annexin V/PI and Hoechst stain and 
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proliferation was observed by measuring Adenosine Triphosphate (ATP) levels in the 
cells.  
The experimental procedure was designed as a means to determine if there was a 
difference in the outcome of CC cell death if the cells were exposed to a single treatment 
with various potencies of R. idaeus or a combined treatment with the optimal potency of 
R. idaeus (D3) with laser 680 nm after a 24 h interval. The single and combined treatment 
protocol was completed a total of 6 times (n=6) for all experiments except for Annexin 
V/PI staining where the experiments were completed a total of 3 times (n=3). The data 
for both experimental procedures were analysed by using Sigma Plot version 14.0 
computer software. The t-test was used in order to examine the effects of the various 
treatment protocols in inducing cancer cell death. In each instance, a statistical difference 
of p<0.05 was identified.  
Morphological changes indicated that the single treatment application of R. idaeus D3 
had the ability to induce CC cell death in vitro however this was not the case in the 
combined treatment protocol of R. idaeus D3 and LLLT 680 nm. The combined treatment 
protocol demonstrated a photobiomodulatory effect which enhanced cancer cell growth.  
Based on statistical analysis, the results demonstrated that a single treatment protocol of 
R. idaeus D3 increased apoptosis of CC cells in vitro. However, more research needs to 
be conducted in order to examine the systemic effects of this remedy preparation.  
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CHAPTER 1.  
INTRODUCTION 
1.1. Foreword 
Cancer is a disease which results from the dysregulation of genes leading to a reduction 
in check-point control accuracy and increased cellular proliferation of abnormal cells 
(Meyerson et al, 2011). Cervical cancer is one of the most prominent cancers which exists 
amongst women, and is considered to occur most commonly in women who have low 
counts of IGF-1 (interstitial growth factor-1) (Serrano et al., 2006). Currently, CC is 
diagnosed by means of a pap smear test which produces false negative results in 5-10% 
of cases (Kitchener et al., 2006). The conventional treatment of CC includes full 
hysterectomy and chemo-radiotherapy (Martin, 2018).  
Homeopathy is a form of complementary medicine which has existed since the early 
1800s after being discovered by a German physician named Dr Samuel Hahnemann 
(Kalra, 2016). This form of medicine has slowly increased in popularity due its low number 
of side effects and affordability. In recent years homeopathic medicine has shown an 
ability to interact on a genetic level due to its newly found nano-particle structure which 
leads to the apoptosis of cancer cells (Saha et al., 2013).  
Rubus idaeus is a plant which contains high levels of antioxidants and polyphenols which 
are believed to reduce tumour volume and incidence (Giao et al., 2012; de Souza et al., 
2014). This plant is typically used as a female tonic in the treatment of female uterine and 
reproductive disorders and has further shown the ability to induce apoptosis in lung 
cancer cells by disrupting the ERK1/2 pathways (Hsieh et al., 2013).  
Low Level Laser Therapy (LLLT) makes use of light emitted at various wavelengths in 
order to promote either tissue rejuvenation of diseased normal tissues or to induce cellular 
apoptosis in cancer cells. The most effective wavelengths observed include those which 
exist between 600-1070 nm (Chung et al., 2012). LLLT promotes cancer cell apoptosis 
by activating the release of cytochrome c-oxidase into the cytoplasm of the cancer cell in 
a non-invasive manner (Bartos et al., 2016; Svanberg et al., 2010).  
  2 
1.2. Statement of the problem 
Cancer has become an incredibly prominent occurrence amongst South Africans, with an 
estimated 47 350 deaths occurring as a result. This large number of deaths is most likely 
associated with the prevalence of obesity, smoking and communicable diseases in South 
Africa. Over time, it has been observed that the mortality rates have increased drastically 
with the percentage of deaths caused by breast cancer being at 21%, prostate cancer 
12% and cervical cancer (CC) 16%. The rapid increase in recorded mortality rates may 
be attributed to an increase in awareness, diagnosis and improved cancer screenings 
(Made et al., 2017).   
Currently there are Human Papilloma Virus (HPV) vaccinations available, however a vast 
majority of women (particularly those who are in the poorer rural areas) do not have 
access to these vaccinations due to insufficient funds and poor access to health clinics. 
Various imaging technologies are used in the diagnosis of CC, such as computed 
tomography and ultrasonography. These techniques however are considered to have a 
low sensitivity and a high occurrence of producing false-positives on screening (Amaro-
Filho et al., 2013).  
The conventional treatment of CC includes intense therapeutic drugs such as cisplatin 
which leads to the development of various side effects (Aredes et al., 2018). A 
comprehensive treatment plan for CC including complementary therapies may increase 
cancer cell death and decrease treatment time to allow for more comfort for patients. This 
could potentially reduce the amount of time in hospitals and further reduce nursing time 
allowing for the patient to potentially return to normal life activities sooner. 
1.3. Aim and Objectives  
The aim of this study was to evaluate the effectiveness of LLLT (680 nm at fluencies of 
5, 10 and15 J/cm2) and Rubus Idaeus homeopathic potencies (D3, D6 and 30cH) on 
cervical cancer cells, in vitro. In addition, the experimental procedure was designed to 
determine if there was a difference in outcome if cells were exposed to a single treatment 
or a combined treatment protocol.  
The study was conducted with the following specific objectives:  
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·       Determine the viability and morphology of CC cells using Trypan Blue assay 
and inverted light microscope after the treatment with R. idaeus (30cH, D6 and 
D3), the optimal potency of R. idaeus and LLLT. 
·       Observe the changes in cellular proliferation and cytotoxicity of CC cells by 
measuring ATP and LDH levels after the treatment with R. idaeus (30cH, D6 and 
D3) and a combination of the optimal potency of R. idaeus and LLLT. 
·       Study the CC apoptotic cell mechanism using flow cytometry and observe 
nuclear damage by Hoechst staining after the treatment with a combination of the 
optimal potency of R. idaeus and LLLT and R. idaeus (30cH, D6 and D3) 
1.4. Importance of the study  
The importance of this study is to continue to identify new additional treatment options in 
the treatment of cervical cancer. This study may demonstrate the ability for alternative 
therapies such as homeopathic medicine and LLLT to treat CC successfully as well as to 
identify the relationship that R. idaeus has with a 680 nm laser when used as a 
photosensitizer. This study serves as the first step towards establishing whether or not 
this treatment could be considered a treatment option in the treatment of CC.  
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CHAPTER 2.  
LITERATURE REVIEW 
2.1. The Cervix 
The cervix or cervix uteri (Latin meaning 'neck of the uterus') is the lower part of the uterus 
in the human female reproductive system. This bulbous, predominantly fibrous organ is 
of great structural and functional importance to the uterus. It plays an integral role in the 
maintenance of pregnancy, conception and the deliverance of a baby (Myers et al, 2015).  
2.1.1. Anatomical Structure 
The cervix is cylindrical in shape and is situated on the uterine corpus at the lower pole. 
The typical length of the cervix is 25 mm with an anteroposterior diameter measurement 
of 20- 25 mm and a measurement of 25- 30 mm transversely (Nott et al., 2016). The 
cervix is divided into two portions; the protio supravaginalis and the portio vaginalis. The 
anatomical location of the cervix can be described as anterior to the rectum and posterior 
to the base of the bladder. A vesicouterine pouch is located between the bladder and 
superior portion of the uterus. Posterior to the cervix is a ligament known as the 
rectouterine pouch and is formed as a result of the reflection of the peritoneal tissue 
inferiorly from the cervix to the posterior vaginal fornix and eventually the rectum. Two 
ligamentus pairs hold the cervix into position, these ligaments are named the transverse 
cervical ligaments (Nott et al., 2016). The main blood supply of the cervix arises from the 
uterine artery with minor contributions from the vaginal arteries which originate from the 
internal iliac arteries. There are four regions of blood supply at the uterocervical junction; 
outer region, a venule and arteriole region, endocervical capillary region and pericanalar 
zone (which contains all small capillaries and veins) (Walocha et al., 2012; Bereza et al., 
2012).  The uterine cervix is collagenous in structure with muscle contributing to 15% of 
its structure. The cervix is supplied by nerves which originate from S2-S4 sacral routes. 
These nerves carry parasympathetic pathways (Abbas et al., 2019). 
2.1.2. Histological Structure 
The cervix contains no glands, however there are cryp-like structures which exist as a 
result of columnar epithelial infoldings. These structures secrete a mucous which function 
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as a means to store spermatozoa after intercourse (Nott et al., 2016). The endocervical 
canal is lined by columnar epithelium which possesses a mucous-secreting function. This 
columnar epithelium layer extends towards the squamous epithelium of the vagina and 
forms an area named the squamocolumnar junction. It is this area which is the most prone 
to malignancy (Beckmann et al., 2010). The cervical stroma consists of 70% type I 
collagen and 30% type III collagen. Overall, the subepithelial stroma consists of 80% 
collagen. The stroma also consists of smooth muscle which has a scattered distribution. 
This smooth muscle is considered to have no function due to the immaturity of fibre (Nott 
et al., 2016).  
2.2. HeLa Cells 
HeLa cells are named after Henrietta Lacks, who died as a result of cervical 
adenocarcinoma in the year 1951. Henrietta Lacks had initially sought help from the 
Johns Hopkins Gynaecology Clinic after experiencing symptoms which included inter-
menstrual bleeding (Surgical Biopsy number 92498, 1951). Upon examination, a 2.54 cm 
lesion was observed on the cervix (Jones, 1997). The cervical Biopsy conducted on 
Henrietta Lacks was given to the Tissue Culture Laboratory in the Department of Surgery 
at Johns Hopkins Hospital for further research to be conducted. Dr Gey and his wife 
Margaret Gey worked in association with Dr Lewis during 1922 in a work associated with 
tissue culture and in vitro investigations (Harvey, 1976). The CC cells of Henrietta Lacks 
were the first cell specimens to grow exponentially, allowing them to become the first cell 
line to be immortalised in tissue culture. From this point onwards, the cells have been 
named HeLa cells in honour of Henrietta Lacks (Lucey et al., 2009). 
2.3. Human Papilloma Virus (HPV) 
Human papilloma virus is a virus which belongs to the Papilloma viridiae family (Harden 
& Munger, 2017) and has a prevalence of 24% amongst women in Sub-Saharan Africa 
(Stewart et al., 2018). Those infected with HPV are usually asymptomatic; however, those 
who display symptoms show signs of lesions on the cervix which are usually self-limiting 
(Doorbar, 2017). Viruses in this family consist of non-enveloped DNA which have an 
affinity for the squamous epithelium (Harden & Munger, 2017). HPV is regulated by 
various factors such as viral integration, methylation and aberrations of the host’s genes 
(Baldwin, 2017). HPV E6 and 7 oncoproteins allow for genomes to be amplified in the 
upper layers of the epithelium, whereby the virus interacts with the adaptive immune 
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response and keratinocytes of the host. The epithelial cells continually proliferate with a 
delay in cell differentiation, thus leading to the development of neoplasia and eventually 
cervical cancer as a result of transformation of atypical cells into cancer cells (Harden & 
Munger, 2017) 
2.4. Cancer 
2.4.1. Background 
Cancer occurs as a result of abnormal cellular proliferation. There are currently more than 
one hundred different types of cancer which exist with each cancer type varying in 
symptomatology and behaviour to therapy. A tumour is considered an abnormal 
proliferation of cells which can result in either malignant or benign growths. The 
distinguishing factors between a benign and malignant tumour are simple; a malignant 
tumour has the ability to metastasise into surrounding tissues whereas a benign tumour 
typically remains contained within its location. Malignant tumours typically metastasise 
via lymphatic ducts and the circulatory system. Tumours are classified in accordance with 
the type of cells that they consist of. Carcinomas are tumours consisting of epithelial cells, 
sarcomas are tumours consisting of various connective tissues such as fibrous tissue and 
bones. Lastly lymphomas and leukaemias are cancers arising from cells which exist in 
the circulatory system (blood cells and immune cells) (Cooper, 2000).  
2.4.2. Cancer Development 
Tumours arise from a single cell which demonstrates an inactivation of the X-
chromosome which is then further converted into heterochromatin. In cancer cells, it has 
been further observed that only one heterozygous allele of the X-chromosome is 
expressed as compared to the normal two (Cooper, 2000). This dysregulation and 
heterogeneity thus result in a disruption in the intrinsic mechanism responsible for cell 
differentiation and proliferation. Cancer cells have the ability to proliferate rapidly and 
continually, due to a destruction in check-point controls at a genetic level (Meyerson & 
Pellman, 2011). The further changes which occur include rearrangment of chromosomes 
along with point mutations. These changes result in a newly termed phenomenon 
“chromothripsis”- multiple genomic rearrangements occuring in a once-off cellular crisis 
(Sephens et al., 2011). Genes which are related to cancer development after undergoing 
a point mutation include; G-proteins (guanine nucleotide-binding protein), N-ras proteins 
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and triphosphate-binding proteins (Koeffler et al., 1991). These mechanisms can be 
observed in infections with Human papillomavirus (HPV).  
Cancer cells possess various types of cellular surface markers such as CD44, CD166, 
CD24 and CD133. These markers allow for each cancer type to be accurately diagnosed 
from primary tumour tissues, however these markers are considered to be unstable in 
somatic cell cancers (Madka & Rao, 2011). 
2.5. Cervical Cancer 
CC is considered the major cause of death amongst women worldwide, with the main 
aetiology being a history of infection with HPV (Chen et al., 2018) particularly strains 16 
and 18 (Markowits et al., 2018). The gene responsible for the formation of CC is named 
the Sox2 gene which causes tumorigenicity and increased cellular proliferation (Ji & Zeng, 
2010).  
2.5.1. Risk Factors, Incidence and Symptoms of Cervical Cancer 
Various risk factors such as participating in intercourse at an early age, having intercourse 
with multiple partners, women over the  age of 40 and multiple pregnancies are said to 
play a major  role in the development of CC (Patil et al., 2018). Some research has 
observed that women with low levels of Insulin like growth factor (IGF)- IGF-I and IGF-II: 
Insulin like factor binding protein (IGFBP)-3 had a significantly higher risk of developing 
cervical cancer (Serrano et al., 2006). CC is more prevalent in women who seldom go for 
cervical screening, or who have avoided screening for five or more years (Williamson & 
Snyder, 2015). Made (2017) observed statistics from 2014 and discovered that in South 
Africa alone, there is an estimated 47 350 deaths which occur as a result of CC. As of 
2017, there is an estimated 500 000 cases of CC reported worldwide each year with 50% 
of those who are diagnosed succumbing to the disease (Harden & Munger, 2017). It has 
been observed that of the women diagnosed with CC, 43% were under the age of 45 and 
20-28% were under the age of 40 years (Wang & Chen, 2018).  
The most common sites of cancer formation after HPV infection include the vagina and 
vulva (Doorbar, 2017), with symptoms ranging from intermenstrual bleeding, foul-smelling 
vaginal discharge, lower abdominal pain and haematuria (Stewart et al., 2018). Some 
women may be asymptomatic, or present with other symptoms such as lower or pelvic 
back pain (Williamson & Snyder, 2015).  
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2.5.2. Pathophysiology 
CC is usually a result of recurrent infection with HPV, particularly strains 16 and 18. 
Infection with HPV results in a change of epithelial cells at the squamocolumnar junction 
(Williamson & Snyder, 2015) leading to invasive CC by driving cells into the synthesis-
phase (Amaro-Filho et al., 2013). E2F proteins, a transcriptase factor, is responsible for 
the transactivation of cellular cyclin-dependant kinases (CDKs) proteins which are 
responsible for viral DNA replication taking place. This DNA replication is responsible for 
the development of cancer. E6 is responsible for the degradation and ubiquitination of 
p53, thus resulting in a decreased effectiveness of the damage response of the cellular 
DNA and therefore leading to secondary mutation accumulation. Nuclear protein MKI67 
is associated with cellular proliferation and is present during the active phases of cell 
cycles. MKI67 is used as a predictive factor for the development of tumours (Amaro-Filho 
et al., 2013). Infection with HPV effects the cell-cycle controls when the viral oncoproteins 
produce perturbation of the cellular cycle controls, resulting in a mild carcinoma in-situ 
(CIN) (Kitchener et al., 2006). The latest findings suggest that a genetic susceptibility is 
of major influence in the development of CC. In fact, the most noticeable observations 
note that a variation in Xeroderma pigmentosum C (XPC) contributes the most to a 
woman’s susceptibility to CC (Patil et al., 2018).  
2.5.3. Screening and Treatment 
The most common form of CC screening is a Pap (Papanicolaou) smear test. This test is 
usually performed in a doctor’s office and may either be completed by the traditional 
smear test or the liquid (ThinPrep pap smear test or SurePAth Liquid-based pap smear) 
test (Williamson & Snyder, 2015). In order for the monitoring of any changes in the 
epithelium to be optimal, the patient should be screened annually for a period of 5 to 10 
years (Kitchener et al., 2006).  The physician will send the sample of tissue to a laboratory, 
whereby results are reported as follows- no abnormalities detected, atypical squamous 
cells, low-grade squamous epithelial lesion, high-grade squamous intraepithelial lesion, 
squamous cell carcinoma or atypical glandular cells (Williamson & Snyder, 2015). In 
South Africa, various guidelines have been put into place with regards to cervical cancer 
screening, which acknowledges the unique health conditions of South African women 
with regards to a high prevalence of both HPV and HIV infections, the existence of both 
private and public healthcare systems and health laboratories. The primary screening for 
HPV is more sensitive towards the detection of pre-cancerous changes and is said to 
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possess a negative predictive value which is better than cytological tests. This specificity 
allows for longer intervals to occur between screenings (Botha & Dreyer, 2017).  
2.5.3.1. Criteria considered for HPV and CC screening 
Screening aims at detecting the unsuspected cancer risk in women who are 
asymptomatic (Botha & Dreyer, 2017). There are various criteria which must be 
considered before screening can take place. Women who are to be screened should be 
no younger than the age of 21, women between the ages of 30 and 65 should have both 
HPV and cytology testing, women over the age of 65 no longer need to be screened if 
they have had 3 negative cytology results or two negative dual screenings. In the case of 
women who have a previous history of stage 2 and 3 cervical cancer, screening should 
be done for at least 20 years after diagnosis (Williamson & Snyder, 2015). In South Africa, 
further criteria suggest that women who test seropositive for HIV should undergo cervical 
screening at the time of diagnosis with HIV. It has been further suggested that women 
who are HIV positive should undergo screening at least every 3-5 years (Botha & Dreyer, 
2017).    
Botha (2017) further explains the management of patients when abnormal results occur. 
If abnormal results are found upon visual inspection using Lugol’s iodine, they 
recommend a biopsy in the case of a possibly invasive form of lesion, chemo therapeutic 
treatment when a small lesion is identified and a large loop excision of the transformation 
zone in the case of a large lesion.  
2.5.3.2. Limitations of Pap smear  
With every test, there are various limitations related. With regards to the pap smear test, 
approximately 5-10% of test results produce a false-negative, an insufficient cellularity 
can occur whereby there are less than 5000 well-visualised cells (Kitchener et al., 2006), 
integrity issues in approximately 10% of samples received by the laboratories and human 
error occurs in 3% of cases. Perhaps the most concerning factor of all, is that the pap 
smear test was designed for the sole purpose of screening of squamous cell tumours, 
thus resulting in an inability to identify other concerning tumours such as adenocarcinoma 
or sarcoma (Williamson & Snyder, 2015). Despite the limitations of the pap smear test, it 
has still managed to significantly decrease the incidence of cervical cancer due to its 
ability to aid practitioners in detecting CC, benign cellular morphology or HPV infection 
(Klobocista et al., 2018).  
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2.5.3.3. Conventional Treatment  
The most common form of treatment for CC (particularly in the case of carcinoma in situ 
stages 2 and 3) is chemo- radiation therapy and in cases of advanced carcinoma a 
hysterectomy is performed (Martin, 2018). Chemotherapy is usually used to treat more 
advanced stages of cancer when tumour sizes exceed 4 cm. The most cytotoxic agent 
used to treat cervical cancer, cisplatin, is usually used in combination with daily pelvic 
radiotherapy which is given as 25 fractions (Aredes et al., 2018). Cisplatin is a 
chemotherapeutic agent which is platinum-based. This chemotherapeutic drug has 
previously shown the ability to enhance the expression of Fas (Fas cell surface death 
receptor) which is a gene responsible for apoptosis (Duenas- Gonzalez et al., 2014). 
Cisplatin is usually used in combination with radiotherapy, however survival rates of 
patients receiving this treatment combination is usually low and brings with it many 
unwanted and serious side-effects (Milrot et al., 2013). 
2.6. Homeopathy 
2.6.1. History of Homeopathy 
Homeopathy was discovered in the 1800s by a German physician Samuel Hahnemann, 
born in the year 1755 (Yadav et al., 2018). Hahnemann studied towards a degree in 
medicine in Erlangen, Germany whereby he would translate books in his spare time. In 
the year of 1789, Hahnemann was translating a book written by W. Cullen about the use 
of Cinchona bark as a means of treating malaria. Hahnemann decided to test the effects 
of the Cinchona bark in a healthy individual, and thus decided to ingest the bark. During 
the period, he noticed a strange development of symptoms which were closely related to 
those experienced by individuals infected with malaria (Vigano et al., 2015). This strange 
development of symptoms led him to develop the hypothesis of a particular healing 
principle stating that, “that which can produce a set of symptoms in a healthy individual, 
has the ability to treat and cure the same set of symptoms produced in a diseased 
individual”. This finding led to the development of a very important homeopathic law 
known as the “Law of Similars” (Ernst, 2016). In the year 1796, Hahnemann wrote and 
published an article titled “Essay on a new principle for ascertaining the curative powers 
of drugs and some examinations of the previous principles”. Later, in 1810, Hahnemann 
wrote his first book titled “Organon of Rational Art of Healing”. It is in this book that all 
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homeopathic principles are listed and explained in exceptional detail, and by which all 
homeopathic practitioners base their method of practice on (Vigano et al., 2015).  
2.6.2. Homeopathic Philosophy and Principles  
Homeopathy is practiced by following several laws and principles which were written by 
the founder Samuel Hahnemann. Perhaps the most important is the Law of Similars and 
second is the Law of Minimal Dose of a remedy in order to increase the therapeutic effects 
of the particular remedy in diseased individuals (Ernst, 2016).  
2.6.2.1. The Law of Similars  
Fisher and others (2015) explain the Law of Similars in a rather scientific fashion, by 
comparing it to Newton’s first law: Every action is matched by an equal and opposite 
reaction. Fisher also mentions another infamous scientific law which states that energy 
cannot be created nor destroyed but can constantly change form as with our health. It is 
this energy that has the ability to effect and either improve or worsen an individual’s 
health. The best way in which to explain the use of the Law of Similars in homeopathic 
practice, would be by making use of the remedy Allium cepa, made from the red onion. 
This remedy is commonly used to treat the symptoms of hay fever, as it produces a set 
of symptoms similar to those experienced in cases of hay fever, such as a running nose 
which burns and becomes red and painful and is associated with bland lachrymation from 
the eyes (Ernst, 2016).  
2.6.2.2. The Law of Minimal Dose  
Homeopathic practice is aware of the toxic side effects which can be elicited onto patients 
when a medicinal substance is taken in its crude and undiluted form. Hahnemann 
believed that the more dilute a substance, the less toxic the substance. However, by 
diluting the substance and succussing (shaking) the remedy, it results in a stronger 
healing energy (Ernst, 2016). A therapeutic effect is established by using the smallest 
amount possible (Callinan, 1996).  
2.6.2.3. Remedy Preparation 
Homeopathic remedies are prepared most commonly in accordance with  the methods 
laid out in the German Homeopathic Pharmacopoeia (Bozzuto & Buzzuto, 2000) however 
other methods such as the American, French and British pharmacopoeia also exist. The 
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preparation of a homeopathic remedy starts with a mother tincture (MT), which is a 
solution produced by macerating a particular substance (plant, animal or mineral) in 
alcohol and diluting this maceration using either a centisimal (cH; 1:100) ratio or a decimal 
(D/X; 1:10) ratio. A homeopathic mother tincture is often further diluted according to the 
previously mentioned ratios, until the desired “potency” is acquired. This series of diluting 
the desired substance is referred to as a “serial dilution”. Between each dilution, the 
remedy is “potentised” and “dynamised”. What this means is that the remedy is 
“succussed” against a hard service either 100 or 10 times (depending on the ratio used 
in dilution) between each dilution (Ernst, 2016).  As an example of this, the remedy which 
will be used in this experiment, R. idaeus, was diluted 3 and 6 times using the decimal 
ratio in order to create a D3 and D6 and 30 times using the centisimal ratio in order to 
make a 30 cH. The mother tincture of R. idaeus is prepared by using the leaves of the 
plant. Some vehicles used include ethanol from concentrations of 20% to 90%, distilled 
water, glycerol or lactose (Bozzuto & Buzzuto, 2000).  
 
Figure 1: Process of producing a Homeopathic remedy (Ernst, 2016) 
2.6.2.4. The Use of a Single Remedy  
When prescribing a remedy, the homeopath aims to match the symptoms of the remedy 
to those of the patient. This is done by reading the symptoms in the homeopathic materia 
medica. The Concordant Reference written by Frans Vermeulen has two symptom 
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categories; the first category consists of symptoms which were obtained during provings 
(as described below). The second category of symptoms includes symptoms obtained 
from clinical cases (Vermeulen, 2015). The use of a single remedy is optimal, as it is still 
unclear as to how different remedies react when taken in unison. Hahnemann also 
believed that using a single remedy prevents confusion with regards to which remedy in 
a complex was responsible for a cure or aggravation of symptoms (Fisher et al., 2015).  
2.6.2.5. Potency Selection  
The use of a particular potency (strength) of a remedy is dependent on several things; 
the stage of the disease, the intellectual state of the individual, how sensitive the individual 
is to the remedy and what condition the homeopath is treating. In the case of the stage of 
the disease, the homeopath would use a medium potency (usually a strength of 30CH) 
to treat an acute or reversible disease. In cases of chronic or irreversible disease, the 
patient will be treated with a low potency (usually a 6CH or lower). When treating purely 
physical symptoms, lower potencies are used and when the patient is experiencing 
symptoms of an emotional or mental nature higher potencies are typically used (Kansal 
& Kaushal, 2017).   
2.6.3. Homeopathic Provings 
Homeopathic remedies are made by using animals, plants and minerals. As previously 
mentioned, homeopathy is based on the practice of the law of similars, therefore it would 
only be beneficial for the homeopath to examine the effects of homeopathic medicines 
on the healthy individual (van Haselen & Hoover, 2018).  
For a proving to take place, the host has to follow a set of drug-proving protocols (Kaur, 
2018). Homeopathic provings make use of a group of homeopaths who are in an optimum 
state of health (Renoux, 2018), who are over the age of 18 and are intelligent enough to 
consent to the practice of a homeopathic proving. During a homeopathic proving, it is 
expected of the participants to make note of the physical, emotional and mental 
symptoms they develop during the course of taking the homeopathic remedy (Fisher et 
al., 2015). It is important for these guidelines to be adhered to, as provings are the main 
source of guidance in the remedy selection process (van Haselen & Hoover, 2018).  
Once the proving has successfully taken place and all participants have stopped 
experiencing symptoms of the remedy, the individual responsible for hosting the proving 
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gathers all the symptoms experienced by the participants. The host will then organise the 
symptoms according to those which appeared the most amongst participants (Teut et al., 
2010), to less common symptoms and then very unusual (referred to as “strange, rare 
and peculiar”) symptoms. These symptoms are then placed in the homeopathic materia 
medica. The symptoms are graded in accordance with their appearance amongst 
individuals in the proving, as follows; most common scores a 4, less common but still 
quite a prevalent symptom scores a 3, a symptom only seen amongst a small number of 
participants scores a two and lastly, a very rare symptom scores a 1. These scores 
according to symptoms experienced by participants are placed in the homeopathic 
repertory for the homeopath to use as a means to “score” and compare symptoms of 
various remedies, before prescribing the remedy which scores the highest for the 
particular patient (Fisher et al., 2015).   
2.6.4. Mechanisms Involved 
It has been observed in recent studies that homeopathic remedies act on the cytosol of 
cells (Beeraka, 2009). Homeopathy is based on the Arndt-Shultz law in which low doses 
stimulate cellular activity, medium doses inhibit cellular activity and high doses destroy 
this activity. In doing so, it enables the body to heal itself via its own capacity (Turner & 
Hode, 2002). Latest research has found the ability for homeopathic remedies to influence 
various genetic expressions of cells. It is believed that homeopathic remedies function by 
either upregulating or downregulating various genes which leads to a correction of genetic 
expression when it has been altered by disease (Das et al., 2011). A study conducted by 
Saha (2013) found that different homeopathic remedies alter different genes.  
2.6.5. The Nanoparticle Structure of Homeopathic Medicines 
Nanomedicine is the practice of medicine which makes use of materials of a nano-scale 
in order to improve both diagnostic and therapeutic outcomes (Feng et al., 2019). 
Nanomedicine in homeopathy can be best explained by examining the relationship of 
hydrogen protons and their spin. Hydrogen protons are the only protons that possess a 
spin which has the ability to align itself when yielded to Bo- a magnetic field. In relation to 
quantum theory, there are two energy levels which correspond to a nuclear moment. 
These energy levels are named parallel and anti-parallel. The parallel energy level is 
considered to be a low-energy level. When energy equivalent to these two energy levels 
is applied (in the case of homeopathic succussion), the atoms transition to an excited 
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state which is then closely followed by a relaxed state. It is during the relaxed state that 
the pre-existing energy of the nucleus is exchanged to surrounding molecules. With this 
theory of nanomedicine, it has been observed that homeopathic remedies contain nano-
particles resembling the original starting substances in potencies as diluted as a 12cH 
(Demangeat, 2013). In accordance with the above nature of protons, it has been noted 
that nanoparticle structure (most specifically in homeopathic remedies made from metal 
materials) is the same amongst different potencies (Upadhyay & Nayak, 2011). A few of 
the remedies which have been analysed for nanoparticle include Natrum muriaticum and 
Aurum metallicum in potencies diluted at ratios of 1:1000, and Hypericum perforatum 6cH 
and CM. Nanoparticles were found to be present in all potencies of the afore-mentioned 
remedies. It is this theory of nanoparticles present in homeopathic medicine that could 
explain how homeopathic remedies have the ability to alter the genetic expression of cells 
and disturb the membrane potential of cells. These findings on nanoparticles in 
homeopathic medicines are relatively new with various theories arising to attempt to 
scientifically explain the mechanism of homeopathic medicines. One particular theory is 
that the nanoparticles interact with cellular membranes resulting in a change in the 
membrane potential of cells via a process known as stochastic resonance (Rajendran, 
2018; Bellavite et al., 2014). More research needs to be conducted however to truly 
understand the effect that homeopathic nanoparticles have on various cellular functions 
and immune responses.   
2.6.6. Homeopathic Remedies in the Treatment of Cancer  
Homeopathic remedies are one of the safest and most cost-effective therapies which exist 
and have been used as a means to reduce the side-effects experienced during 
chemotherapeutic treatment, and recently even as a means to treat various cancers 
(Yadav et al., 2018). Evidence has observed that homeopathic remedies  (particularly 
Conium maculatum, Sabal serrulata, Thuja occidentalis and Carcinosin) have the ability 
to reduce  tumour incidence, progression, weight and volume of tumours (Jonas et al., 
2004). Thuja occidentalis has been shown to posess the ability to suppress vascular 
endothelial growth factor (VEGF), angiogenin-4 and CD31 (platelet endothelial cell 
adhesion molecule) expression in cancer cells (Torres et al, 2016). A study conducted in 
2006 observed the anti-neoplastic effects of homeopathic remedies ( T. occidentalis 
(1000cH), C. maculatum (1000cH), S. serrulata (200cH), Carcinosin (1000cH)) in rats 
which were injected with MAT-LyLu prostate cells. The study found that in 23% of the 
rats, there was a significant reduction  in tumour incidence and tumour volume in rats 
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treated with the homeopathic remedies. The study thus concluded that homeopathic 
remedies have the ability to increase apopotosis in cancer cells (Jonas et al., 2006).  
Remedies have further shown the ability to inhibit the development of melanoma and 
metastasis in mice which were injected with B16F10 melanoma cells (Ferrari et al, 2016).  
Homeopathic treatment in breast cancer has shown commendable results where the 
homeopathic remedies used were Carcinosin 30cH, Phytolacca decandra 200cH, C. 
maculatum 3CH and T. occidentalis 30cH, 200cH and 1M ( Frenkel et al, 2010). Further 
research into the effect of homeopathic remedies on the gene expression in HeLa cervical 
cancer cells has shown the ability of homeopathic medicine to completely change the 
expression of 6024 genes in these cells (Saha et al., 2013).  
2.7. Rubus idaeus L. 
Rubus idaeus L. species, commonly known as Red Raspberry, is a plant belonging to the 
Rosaceae family, under the subgenus Idaeobatus with biennial stems and fruit (Tobyn et 
al., 2011). R. idaeus contains a large number of antioxidants, particularly anthocyanin 
and ascorbic acid (de Souza, 2014). A study completed in 2005 by Anttonen & 
Karjalainen, found that R. idaeus contained high levels of quercetin and ellagic acid 
(Tobyn et al., 2011). The polyphenols from R. idaeus are absorbed by the body in various 
as degradants. The most common polyphenols found to exist in R. idaeus include 
cyaniding-3-O-sophoroside, cyaniding 3-O- glucoside, lambertianin C and sanguiin H6 
(Zhang, 2018).  
2.7.1. Clinical uses of Rubus idaeus 
The polyphenols in R. idaeus possess many antioxidant, anti-tumour, antimicrobial and 
anti-inflammatory properties (Giao et al., 2012), along with the ability to induce metabolic 
detoxification (Milbury, 2009). R. idaeus has the ability to decrease risk biomarkers for 
obesity and diabetes, by reducing the levels of plasma interleukin (IL)-6 by enhancing the 
activity of glutathione peroxidase in the liver (Noratto et al., 2017). It has also been found 
that R. idaeus has the ability to decrease inflammatory and oxidative stress involved in 
the promotion of heart morphological changes in the elderly. R. Idaeus does so by 
downregulating proteins such as natriuretic peptide precursor type A and glutathione S- 
transferase A4 (Noratto et al., 2016). New research has found that R. idaeus extract has 
the ability to reduce signs and symptoms related to arthritis, by reducing soft tissue 
swelling, formation of osteophytes, reduction in particular destruction and bone resorption 
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(Figueira et al., 2014). Impressive neuroprotective properties are also produced by its 
fruit, whereby R. idaeus has the ability to increase the activity of catalase in human 
neuroblastoma SH-SY5Y cells (Zhou et al., 2018).  
2.7.2. R. idaeus and Cancer Cells 
No research has been done with regards to the effect of R. idaeus as a homeopathic 
preparation on CC cells, however there is substantial evidence showing the anti- 
neoplastic effects of herbal preparations of R. idaeus. A study conducted in 2013 
observed that herbal preparations of R. idaeus has the ability to reverse epithelial to 
mesenchymal transition in cases of lung cancer. The study noted that R. idaeus did so 
by targeting the FAK (focal adhesion kinase) and ERK1/2 pathways (Hsieh et al., 2013). 
Further research identified the ability of R. idaeus to destabilise cancer cells by 
penetrating the cell membranes (Cho et al., 2016).  
2.8. Low Level Laser Therapy (LLLT) 
A laser is a device which emits light via a process involving optic amplification as a result 
of emission of photons. LLLT is a form of complementary therapy (Chung-Sik et al., 2004), 
which was discovered in the 1960s by Endre Mester. Cells are exposed to low levels of 
near infrared or red light at low energy densities in order to promote healing. Another term 
given to LLLT is “cold laser therapy”, due to the low power densities used to prevent the 
heating of tissue (Chung et al., 2012).  
2.8.1. History of Low Level Laser Therapy 
Lasers were discovered in the early 1960s, after Townes observed that it was possible to 
create short-waves by manipulating ordinary light. However, it was Arthur Schawlow who 
created the way in which light waves could be emitted effectively. He noticed that the best 
way to emit waves would be to place the atoms in a narrow and long cavity with mirrors 
attached at each end, so as to allow for the waves to radiate. Gorden Gould further added 
to the development of the laser by investigating ways in which to “pump” atoms to higher 
energy states to emit light. It was Gould who developed the name “Laser” which stands 
for “Light Amplification by Stimulated Emission of Radiation”. The trio of scientists further 
studied the benefits of using various gases and crystals as a means of increasing the 
energy of atoms (Weart, 2019). The use of low level laser began after the development 
of the ruby laser in 1960 along with the Helium-neon laser which was created in 1961. 
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Endre Mester, who worked at Semmelweis University in Budapest, was the first to 
observe the benefits of laser in a therapeutic setting. He observed this when he applied 
laser light to hairless mice, who began to grow hair after treatment with a Helium-Neon 
(HeNe) laser. After his discovery, Mester treated patients with skin ulcers which did not 
heal (Chung et al., 2012).  
2.8.2. Sources of Light  
There are currently several different sources of light which are used in LLLT. Light 
emitting diodes (LEDs) have currently become a more popular source of light for lasers, 
along with gallium arsenide (GaAs) semi-conductor diode lasers. Another common 
source of light used in lasers is the He-Ne, a gas which emits light at a wavelength of 
632.8 nm. The increased popularity of light emitting diodes (LEDs) has developed due to 
the fact that LEDs have the ability to emit light over a much wider range of wavelengths 
than any of the other lasers. With new technology becoming available, the latest source 
of light currently under investigation is the organic LEDs with an electroluminescent layer 
which emits light in response to an electrical current (Agostinis et al., 2011) 
2.8.3. Mechanisms and Laser Parameters 
There are three components which are important to the functioning of a laser; oxygen, 
light and photosensitizers (Agostinis et al., 2011). 
2.8.3.1.  Photosensitizers 
Photosensitizers are otherwise referred to as dyes which can absorb, reflect and transfer 
the energy of the light emitted by the laser into other molecules in order to bring about 
photochemical reactions (Wainright, 2004). These photosensitizers function by absorbing 
light at various wavelengths and further converting the light into fluorescence and different 
atomic arrangements. This conversion process leads to a transference of energy across 
oxygen molecules and further leads to the formation of reactive oxygen species 
(Dougherty et al., 1998). Photosensitizers are generally placed into two groups, namely 
those which are non-porphyrin based or porphyrin based. Photosensitizers which fall into 
the porphyrin-based category include chlorins, phthalocyanines and bacteriochlorin. 
Photosensitizers such as cyanines, psoralens, anthracyclines and hypericin fall into the 
non-porphyrin-based category (Ormond, 2013; Wainright, 2004). In order for a 
photosensitizer to be considered “ideal” in nature, various characteristics need to be met. 
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These characteristics include the ability for a photosensitizer to be water-soluble, 
chemically stable, possess a high yield of oxygen generation, be able to accumulate 
rapidly in target tissues and possess a molar coefficient anywhere between 600- 900 nm 
(Yano et al., 2011; Mehraban et al., 2015).   
2.8.3.2. Dose 
The dose of a laser, also referred to as the fluency, is defined as the energy of light which 
is directed at a particular unit of area during a given period of time. The unit of 
measurement used is joules per centimetre squared (J/cm2). The dose is calculated by 
taking in consideration the power of the laser’s output (measured in watts) and multiplying 
this measurement by the duration of treatment (in seconds). This is summarised in the 
formula below:  
Dose= (Power (W) x time (s)) ÷ area treated (cm2) (Turner & Hode, 2002) 
2.8.3.3. Power Density 
The power density, also referred to as the density of light emitted by the laser, indicates 
the power output concentration. This power output is calculated by taking into account 
the area (cm2) of target tissue. The area of treatment and the power density have an 
inverse relationship, meaning that the larger the treatment area, the lower the power 
intensity will be (Turner & Hode, 2002).   
2.8.3.4. Mechanisms 
LLLT follows the principles of Arndt-Schultz law, in which weak stimuli activate cellular 
activity, moderate stimuli inhibit this activity and intense/high stimuli destroy cellular 
activity (Bresler, 2012). LLLT is believed to induce photochemical reactions in the cells 
via a process known as photobiomodulation (Chung & Dai, 2012). LLLT consists of very 
slow irradiation intensities which stimulate healing of damaged cells (Chun-sik et al., 
2004).  LLLT has an effect on tissues due to a phenomenon whereby air and tissue 
refractive indexes change as a result to light being reflected. This can be summarised by 
the law of Snellius (Chung et al., 2012);  
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1 represents the angle between normal air surface and light, 2 represents the angle 
between normal tissue surface and laser ray, n1 represents air refraction index and n2 
represents tissue refraction index. This calculation notes that light has a “scattering 
behaviour” in tissue which effects the light intesity and volume distribution in tissues 
(Chung et al., 2012). LLLT makes use of infrared  (700 - 1000 nm) and visible radiation 
(380 - 700 nm), as well as fluence- the level of energy per area of a particular size. 
Fluence is expressed by Joules per centimetre squared. Another inclusion in laser 
parameters is the power density expressed in Watts per centimetre squared (Vero, 2013).  
The light wavelengths which are typically used in LLLT fall into a range of red and near-
infrared wavelengths of 600- 1070 nm (Chung & Dai, 2012).  
2.8.4. Laser Interaction With Tissue 
The most effective wavelengths used to penetrate tissue are between 600-1070 nm, with 
haemoglobin and melanin absorbing wavelength bands shorter than 600 nm. Superficial 
conditions are usually treated at wavelengths of 600-700 nm and deeper tissue is 
penetrated with wavelengths ranging between 780-950 nm. Recently it has been 
understood that LLLT has an effect on the mitochondria of cells, resulting in an decreased 
level of adenosine triphosphate (ATP), increased level of reactive oxygen species and 
transcription factor induction (Chung et al., 2012). Laser also has a large influence on the 
endoplasmic reticulum (ER) of cells (Dewaele et al., 2011).  
LLLT affects the ER by causing an activation of the caspase-12 dependant pathway 
(Dewaele et al., 2011) by cleaving caspase-12 with protease m-Calpain (Rao et al., 2002; 
Nakagawa et al., 2000). Photodynamic therapy (PDT) (the use of LLLT in vitro to promote 
tissue repair) effects mitochondria resulting in an increase in cell proliferation and 
migration along with modulation of growth factors, cytokines and increased oxygenation 
of tissue (Chung et al., 2012). Cytokine expression has also been shown to reduce in the 
presence of a laser, by reducing levels of IL-1 and IL-6 (Bartos, 2016). Further studies 
have shown that different cells react differently to LLLT. One study observed that 
fibroblast cells have a lower sensitivity to laser irradiation than keratinocyte cells. The 
level of reactive oxygen species in keratinocytes was significantly higher than that found 
in fibroblast cells, whereas fibroblasts had a higher basal catalase expression when 
treated with laser (Engel, 2016).  
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Further research into the effect of LLLT’s relationship with immune cells such as mast 
cells and leukocytes have shown that certain wavelengths have the ability to cause 
degranulation of mast cells, which thus results in the release of cytokine TNF-. With this 
action taking place, there is an increase in the number of leukocytes infiltrated into the 
tissues. LLLT has also shown the ability to increase epithelial cell motility and 
proliferation, which thus increases the rate of wound healing. When laser is applied to 
cells, it results in a photon of light to be absorbed by chromophores. Once the photon is 
absorbed, an electron will jump from an orbit of low energy, to an orbit of high energy. 
This movement of electrons promotes the activation of various cellular tasks (Chung & 
Dai, 2012). ). Currently, LLLT is used as a means of treatment for the side effects 
experienced by patients undergoing chemotherapy and radiation therapy. Such side 
effects include lymphadenopathy in women with breast cancer and oral mucositis 
(Ferreira et al., 2016). In the case of lymphoedema in patients with breast cancer, the use 
of LLLT at an energy density of 1-2 J/cm2 allowed for a large reduction in arm 
circumference (Omar et al., 2012). 
LLLT can be used in conjunction with a photosensitizer, resulting in a therapeutic 
approach known as photodynymic therapy (PDT). A large amount of research has been 
conducted in order to observe how the addition of a photosensitizer to LLLT may effect 
cells in vitro and how this PDT may induce apoptosis in cancer cells.  
Apoptosis is a term applied to the morphological component of cell death. This process 
is typically recognized by nuclear fragmentation, cell volume reduction and chromatin 
condensation. Unprogrammed apoptosis occurs in the presence of an external influence 
(for example LLLT or PDT when applied to cells) and programmed apoptosis occurs when 
cells fail to meet normal chromosomal structure during the proliferation process, and 
therefore die as a result (Kroemer et al., 2009). LLLT and PDT are both cost-effective and 
non-invasive in their therapeutic approach, which has led to increased use and popularity 
of the years (Svanberg et al., 2010). The main mechanism of cell death as a result of PDT 
is the formation of ROS via two pathways- Type I (produces free radicals and radical ions) 
and Type II (a singlet oxygen is produced due to energy transference from the 
photosensitizer to a triplet oxygen) (Kim et al., 2017). The formation of these ROS leads 
to cyto-damage of carcinogenic cells and further autophagy, apoptosis and cellular 
necrosis (Robertson et al., 2009).  
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A photosensitizer named pheophorbide has demonstrated the ability to induce apoptosis 
in androgen-insensitive prostate cancer cells (Lin et al., 2015) when combined with a 
laser of 670 nm wavelength at a fluency of 5 J/cm2 (Xu et al., 2011). Research has further 
shown that this combination of laser and pheophorbide prevents prostate cancer cells 
from forming colonies (Gheewala et al., 2018). With regards to MCF-7breast cancer cells, 
PDT has demonstrated a remarkable ability to produce a cytotoxic effect when used at a 
fluency of 15 J/cm2 in combination with phthalocyanines (Horne et al., 2012). A chlorin-
based photosensitizer named chlorin-bexarotene has shown a tremendous ability to 
induce cytotoxicity in triple-negative breast cancer cells by targeting vitamin A nuclear 
receptors (Isaac-Lam et al., 2019). Research has further supported the ability of a 680 
nm laser, when combined with ZnPcSmix, to induce cancer cell death in human colon 
(DLD-1) and lung (A549) cells by localising in the lysosomes and mitochondria (Manoto 
et al., 2012). This research has been further concluded with the addition that the best 
performing dose at 680 nm wavelength is 5 J/cm2 (Manoto et al., 2013). In the case of 
CC, a study conducted by Chizenga (2019) found that PDT at a wavelength of 673.2 nm 
in combination with AIPcSmix proved effective in inducing apoptosis in cervical cancer 
stem cells in vitro.  
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CHAPTER 3.  
METHODOLOGY 
3.1. Research Procedure and Design 
This quantitative in vitro research study, took place at the Laser Research Centre of the 
University of Johannesburg. This research study made use of HeLa cells, R. idaeus (D3, 
D6 and 30cH homeopathic preparations) and LLLT at 680 nm with 5, 10 and 15 J/cm2 
fluencies. A flow diagram showing the summary of the research process is shown in 
Appendix A.  
3.1.1. Chemicals and Media Used 
Refer to Appendix B, C and D for a table demonstrating the list of chemicals, media and 
products used for this study.  
3.1.2. HeLa Cell Culture 
CC HeLa cells (ATCC CCL-2) were grown in Dulbecco’s Modified Eagle Medium (DMEM) 
complemented with Fetal Bovine Serum (FBS) (10%) (FBS; Gibco 306.00301) and 
penicillin/streptomycin (1%) (PAA Laboratories GmbH, P11-010). Cells were then 
cultured at a temperature of 37oC with 5% CO2 and 80% humidity. CC cells were sub-
cultured on a weekly basis. Once cells had become confluent, they were washed with 
Hank’s Balanced Salt Solution (HBSS, Invitrogen, 10-543F) and dissociated using 
TrypLE (1 ml/25 cm2) (Gibco, 12604). Cells were then seeded in culture plates (1x106) 
with a diameter of 3.5 cm2 and allowed to incubate for 6 h in order to become attached 
before experiments. 
3.2. Rubus idaeus Remedy Preparation and 
Administration 
Fusion Homeopathics homeopharmaceutics company used R. idaeus MT, prepared by a 
company named Herbamed by using the fresh leaves of the plant, in order to create the 
D3, D6 and 30cH potencies required for experiments. The Homeopathic Pharmacopoeia 
(HAB) 3a method was followed for mother tincture preparation and plant used contained 
60% moisture. This dilution method is conducted by using a ratio of 3:7 (mother tincture: 
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ethanol 62%) for the creation of the D3 and D6 potencies and 3:97 (mother tincture: 
ethanol 62%) for the creation of the 30cH potency. Once remedies had been created in 
their relevant potencies, they were stored in 20 mL amber glass bottles which had been 
previously sterilized and placed in a temperature controlled room of 20oC with no sunlight. 
Each potency was administered at a dose of 40 L before incubating at 37oC with 5% 
CO2 and 80% humidity for 24 h (Appendix E).  
3.3. Cell Treatment 
There were three experimental cell groups in this study, whereby each group underwent 
experiments which were repeated three times in duplicate. The layout of the experimental 
cell groups were completed in accordance with the table below:  
Table 1. A Table Summarizing the Layout of Experimental Cell Groups used in 
Experimental Procedures 
Group 
number 
Description of Experimental Cell Group 
1 CC cells not exposed to R. idaeus or a combination of R. idaeus 
(optimal potency) and LLLT- untreated control 
2 CC cells treated with R. idaeus (D3, D6 and 30cH)  
3 CC cells treated with a combination of the optimal potency of R. 
idaeus and 680 nm diode laser at three fluencies of 5,10 and 15 
J/cm2 
The different cell groups were monitored with regards to their levels of lactate 
dehydrogenase (LDH) release. Adenosine triphosphate (ATP) levels were measured as 
a means of assessing cellular proliferation. Trypan Blue assay and an inverted light 
microscope were used to assess changes in cell viability and morphology. Lastly, the 
apoptosis of the HeLa cell culture was measured via Annexin V/PI and Hoechst staining.  
3.4. Laser Irradiation 
A diode laser (Oriel Corporation, USA, LREBT00-ROITHI) emitting at a wavelength of 
680 nm supplied by the National Laser Centre of South Africa was used for this study. 
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Before cell irradiation, a power meter (FieldMate) was used to determine the power output 
of the laser. The power output of the meter measured at 201 mW. The intensity of the 
laser was calculated and the measurement was 22.15 mW/cm2 for cells that were 
irradiated for ATP, LDH, morphology and viability assays. The cells were then irradiated 
for 3 min 47 sec, 7 min 34 sec,11 min 22 sec to provide an energy of 5, 10 and 15 J/cm2. 
For cells irradiated for the Hoechst and Annexin V/PI experiments the laser output was 
measured at 205 mW and a laser intensity of 22.59 mW/cm2 was attained. For this 
experiment cells were exposed to laser at times of 3 min 37 sec, 7 min 14 sec and 10 min 
52 sec to provide an energy of 5, 10 and 15 J/cm2 respectively. A Table summarising 
these laser parameters used can be found in appendix F and the calculations used to 
work out laser parameters can be found in Appendix G.  Culture plates containing cells 
and the optimal potency of R. idaeus were irradiated in the dark at 5, 10 and 15 J/cm2 
fluencies whereas irradiated cells without the R. idaeus were used as laser control.  
 
Dosage calculations were determined as follows:  
 
Irradiance (J/cm2) = time (s) × [power (W)/ surface (cm2)].  
 
Post irradiation assays were then carried out after 24 h of incubation at 37oC. Appendix 
F demonstrates the laser parameters used in this study.  
 
 
Figure 2: The 680 nm laser diode used at the Laser Research Centre, University of Johannesburg.  
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3.5. Cellular Dose Response Assays 
3.5.1. Cellular Viability 
The trypan blue assay was used as a means of evaluating the percentage of viable cells 
after treatment with R. idaeus (RI) and a combination of RID3 and 680 nm laser diode at 
doses of 5, 10 and 15 J/cm2. An equal volume (10 L) of suspended cells and 0.4% 
Trypan blue were mixed before being transferred to a Neubauer haemocytometer 
(CountessTM Automated Cell Counter, Invitrogen) in order to count the number of living 
and dead cells 
3.5.2. Cellular Proliferation 
Twenty four hours after administration of a single treatment of RI30cH, D6 and D3 and 
then a combination of the optimal potency of RI (D3) with 680 nm laser at doses of 5, 10 
and 15 J/cm2, CellTiter-Glo luminescent (Promega G7573) assays were used as a means 
of evaluating cellular proliferation via ATP quantification. An equal volume of ATP reagent 
(50 L) was added to cells suspended in HBSS and mixed well. The mixture was then 
incubated in dark for 10 min. The luminescence signal was measured using a 1420 
Multilabel Counter Victor3 (Perkin-Elmer, VICTORTM). 
3.5.3. Cellular Cytotoxicity 
Cell cytotoxicity was measured 24 h after administration of RI30cH, D6 and D3 and a 
combination of the optimal potency of RI (D3) and 680 nm laser at doses of 5, 10 and 15 
J/cm2.  The LDH assay measured the integrity of the cellular membranes. An equal 
volume (50 L) of Cyto-TOx96 (Anatech Promega G400) was added to cells suspended 
in DMEM and incubated for 30 min. After incubation LDH levels in the culture media were 
captured at 490 nm (Perkin-Elmer VICTORTM).  
3.6. Cell Death Analysis 
3.6.1. Analysis of Apoptosis (Annexin V/PI) 
The optimal potency of RI (D3) individually and in combination with LLLT 680 nm at doses 
of 5, 10 and 15 J/cm2 were used to study the cell death analysis using Annexin V/PI 
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staining. Untreated control cells were also analysed using Annexin V/PI staining in order 
to compare findings from the two treated cell groups. Flow cytometric analysis (BD 
Accuri™ C6 Cytometer) was used to analyse the relative size, internal density and 
fluorescence intensity of cells as they flowed in a liquid passing through a beam of light. 
Before experimentation, cells were centrifuged at 300 x g-1 for 5 min at a temperature of 
20oC. After being centrifuged, the TE/HBSS mixture was pipetted out before cells were 
aspirated in 10 mL of cold PBS. Once cells were re-suspended in PBS, they were 
centrifuged again at a speed of 300 x g-1 for 5 min at a temperature of 20oC. This process 
was repeated twice. Annexin V- fluorescein isothiocyanate (FITC) apoptosis detection kit 
(Becton Dickinson, 556570, Scientific Group, South Africa) was used to detect the 
percentage of cells which underwent apoptosis. FITC is a fluorochrome attached to 
Annexin V, a protein complex with high affinity for phosphatidylserine. Externalization of 
phosphatidylserine to the plasma membrane occurred in early apoptosis that facilitated 
the binding of FITC Annexin V. Propidium iodide (PI) is a vital dye used in conjunction 
with FITC Annexin V to differentiate viable cells (FITC Annexin V negative and PI 
negative) from non-viable cells. Cells were incubated with FITC Annexin V and PI at room 
temperature for 10 min and analysed by flow cytometry, which detected a green 
fluorescence for FITC Annexin V and red fluorescence for PI.  
3.6.2. Nuclear Damage Using Hoechst Stain 
Once the optimal potency of RI had been established (D3), it was combined with 680 nm 
laser at doses of 5, 10 and 15 J/cm2. RID3 as a single treatment protocol was compared 
to cells irradiated at 5, 10 and 15 J/cm2 in combination with RID3 and compared to 
untreated control cells.  After the treatment of HeLa cells, the nucleus was stained with 
Hoechst dye (33342/33258) (10 mg/mL). A mixture of Hoechst dye with Phosphate-
buffered saline (PBS) in a dilution of 1:5000 was then incubated for 30 min at room 
temperature. Thereafter, the PBS was replaced immediately before the fluorescence was 
measured at 355 nm excitation and 455 nm emission from Carl Ziess Axio Z1 Observed 
with DAPI Filter set. The nuclei of various cell groups were then analysed for any 
appearances of nuclear shrinking or degradation as compared to the untreated control 
groups of cells. Live cells’ nuclei absorb the Hoechst dye whereas dead cell nuclei do not.  
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3.7. Reliability and Validity Measure 
Optimum temperatures were considered with regards to cellular incubation (37oC at 5% 
CO2) and cellular stocks in liquid nitrogen and in -80oC deep freezer. During passaging 
of cells, flasks were labeled according to passage number and date of passage so as to 
allow for accurate identification. Petri dishes were labeled according to the subculture 
group numbers. Cell lines were handled with appropriate care, with use of gloves and 
mouth masks so as to prevent any forms of contamination.  
3.8. Data Collection and Analysis 
The experiments were repeated three times in duplicate. The untreated cells formed the 
control, which were then used to compare the treated cells using ANOVA to determine 
the statistical difference. The data was statistically analysed by using software SigmaPlot 
version 14. The significance between the groups is shown as p<0.05(*), p<0.01(**) and 
p<0.001(***).  
3.9. Ethical Consideration 
A commercial cell line procured from ATCC (HeLa cells CCL-2) was utilised to conduct 
the in vitro studies.  
Cells are readily available and kept in liquid nitrogen stocks in the LRC laboratory. 
Guidelines on the ethics standards for obtaining human materials from ATCC can be 
viewed on their website (https://www.lgcstandards-
atcc.org/About/About_ATCC/Ethical_Standards_for Obtaining Human Materials.aspx), 
and all ethical standards have been met by ATCC when isolating these cells. Donation of 
the tissue is anonymous, and the cell lines cannot be traced back to the donors (Appendix 
H). The certificate of analysis can be found in Appendix I. The LRC has also received the 
necessary biosafety clearance required from ATCC when ordering such cells (Appendix 
J). A letter from the research ethics committee as well as a letter from the higher degrees 
committee authorising the commencement of this study are found in Appendices K and 
L. Plagiarism report can be found in Appendix M.  
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CHAPTER 4.  
RESULTS 
This in vitro study aimed to identify the effects of homeopathically prepared R. idaeus (RI) 
on CC HeLa cells by observing the effects of this homeopathic medicine individually and 
in conjunction with the 680 nm diode laser. The first set of experiments were conducted 
as a means of identifying the best performing potency of the homeopathically prepared 
RI. After identifying that, the optimal potency was RID3, this potency was then used in 
conjunction with the 680 nm laser at doses of 5, 10 and 15 J/cm2 in order to identify the 
synergistic effects.  
In both treatments, cells were examined using an inverted light microscope in order to 
observe the morphological changes of CC after treatment. The cytotoxic effects of both 
treatment protocols were examined using Trypan blue assay as explained previously and 
measuring the LDH released by dead cells after treatment were also measured. ATP 
levels were measured as a means to see whether the treatment protocols were able to 
decrease production, therefore indicating unfavourable cellular environments for survival.  
Results were further scrutinized by using the Annexin V/PI staining in order to confirm the 
findings observed in the above-mentioned experiments, and finally Hoechst staining was 
completed as a means of observing the effects of treatment protocols on the cellular 
nuclei.  
4.1. Dose Response Studies 
4.1.1. Cellular Morphology 
The morphological changes of cells treated with RI in potencies of 30cH, D6 and D3 as 
well as cells treated with a combination of the optimal potency of RI (D3) and 680 nm 
laser at doses of 5, 10 and 15 J/cm2 were compared to untreated control cells as shown 
in Figure 3. The morphological features of CC HeLa cells were determined using inverted 
light microscopy to analyse the ability of RI and a combination of the optimal potency of 
RI the 680 nm laser diode to induce apoptosis after 24 h incubation.  
With the experiment conducted to identify the optimal potency of RI, the D3 potency 
demonstrated an ability to induce blebbing of the CC HeLa cells. With blebbing the cellular 
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membranes seemed to show a loss of integrity as compared to the membrane of control 
cells. Dead cells could be observed floating in the medium. With regards to the D6 
potency, there seemed to be no significant changes with regards to the cellular 
membranes when compared to the control. Fewer dead cells could be observed floating 
in the medium as compared to those seen in the cells treated with D3. Lastly, cell treated 
with the 30cH potency appeared to have become overly confluent on the plate as 
compared to control cells. Membrane integrity seemed intact and no dead cells could be 
observed floating in the medium.  The laser irradiated cells were combined with the 
optimal potency of RI (D3 potency). CC HeLa cells irradiated with a combination of the 
optimal potency of RI (D3) (RID3) and 680 nm laser at 5 J/cm2 appeared to have no 
changes in cellular membrane integrity or nuclei shape when compared to untreated 
control cells. No dead cells could be observed floating in the medium along with no 
blebbing of cells. Cells irradiated with a combination of RID3 and 680 nm laser at 10 J/cm2 
also seemed to demonstrate an no changes in cellular structure when compared to 
control cells. There appeared to be no blebbing or dead cells floating in the medium. 
Lastly, cells irradiated with a combination of RID3 and 680 nm laser at 15 J/cm2 appeared 
to demonstrate a decreased number of viable cells as compared to the untreated control 
cells. Cellular structure and membrane integrity, however, did not appear to be 
significantly different when compared to untreated control cells. Few dead cells could be 
seen floating in the medium.  
 
 
 
 
 
 
 
Figure 3: Morphological analysis of CC cells. Fig 2(a) and 2(e) represents the untreated control 
cells, (b) represents D3 potency, (c) D6 potency and (d) 30cH potency, (f) RID3 + 5 J/cm2, (g) 
RID3 + 10 J/cm2 and (h) RID3 +15 J/cm2. The black arrows demonstrate dead cells. 
a b c d 
e  f  g  h  
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4.1.2. Cellular Viability Using Trypan Blue Assay 
The percentage of viable cells were compared to that of control cells. Trypan blue dye is 
absorbed by dead cells and not viable cells, allowing for a count to be conducted on the 
percentage of viable cells. The control cells demonstrated a viability of 74%. CC HeLa 
cells treated with RI30cH had an average increase in viability of 82% (p<0.186), whereas 
cells treated with RID6 showed a reduction in the cellular viability, with an average 
percentage of 61% (p<0.283). Cells treated with RID3 showed a significant reduction in 
cellular viability with an average viability of 59% (p<0.292). The results depicted in the 
Figure 4 demonstrate the average viability results obtained per group. In the experiment 
comparing the combined effects of RI in a D3 potency and 680 nm laser, cellular viability 
of treated cells were compared to the cellular viability of control cells (75%). Cells treated 
with a combination of RID3 at 680 nm laser irradiation at a dose of 15 J/cm2 demonstrated 
an average viability of 59%. Cells treated at RID3 + 10 J/cm2 showed a viability of 53%. 
Lastly, cells treated at a dose of RID3 + 5 J/cm2 depicted a viability of 60% respectively.  
The results of the combined experiments in 5 J/cm2 (p<0.88), 10 J/cm2 (p<0.41) or 15 
J/cm2 (p<0.80) did not show any statistical significance.  These results are shown in 
Figure 5. 
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Figure 4: Viability of CC cells after the treatment with RI . Percentage of Viable cells after 24 h 
treatment with RI30cH, D6 and D3. The mean percentage value has been depicted with the 
control demonstrating a viability of 74% Cells treated with RI30cH demonstrated an average 
viability of 82%, cells treated with RID6 showed 61% and D3 showed 59% respectively. 
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Figure 5: Viability of CC cells after the treatment with RID3 and 680 nm laser. Cells treated with 
RID3+ 15 J/cm2 had a viability of 59% whereas cells treated withRID3 + 10 J/cm2 had a viability 
of 53% and cells treated with RID3 + 5 J/cm2 showed 60% respectively. 
4.1.3. Adenosine Triphosphate (ATP) Proliferation Assay  
ATP levels of treated groups were compared to those of the control groups in order to 
determine a statistical significance. The methodology of this experiment can be found 
under 2.5.  Cells treated with RI30cH resulted in an increase in ATP levels (p<0.945) 
whereas cells treated with RID6 did not show much difference in ATP levels (p<0.411) as 
compared to the control cells. Cells treated with RID3 demonstrated a decrease in ATP 
levels as compared to the other two treatment groups and the control (p<0.194).  
Cells treated with a combination of RID3 and 680 nm Laser at 5, 10 and 15 J/cm2 showed 
a remarkable increase in ATP levels as compared to untreated cells. With the significance 
of cells treated at RID3 + 5, RID3 + 10 and RID3 + 15 J/cm2 showing significance of 
p<0.001, 0.004 and 0.001 respectively. All results are demonstrated in Figure 6 and 7. 
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Figure 6: ATP proliferation after treatment with RI. Cells treated with the 30cH potency 
demonstrated no difference in ATP levels as compared to the control, the D6 treatment group 
demonstrated an increase in ATP levels and the D3 treatment group demonstrated a decrease in 
ATP levels (p<0.194).  
 
  35 
 
Figure 7: ATP proliferation after combined treatment with 680 nm laser and RID3. The results 
demonstrate an increase in ATP levels in cells treated with RID3 + 5, 10 and 15 J/cm2. p<0.001 
*** and p<0.01 ** 
4.1.4. Lactate Dehydrogenase (LDH) Assay 
LDH levels were measured 24 h after treatment with RI30cH, D6 and D3. All treatment 
groups were compared to the control group. All potencies of RI had an effect on the levels 
of LDH. RI30cH (p<0.11) and D6 (p<0.08) decreased the levels of LDH released by cells 
whereas, RID3 increased the levels of LDH (p<0.212) as compared to the control group 
(Figure 8).  
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In the combined treatment of RID3 with 680 nm laser at 5, 10 and 15 J/cm2. LDH levels 
increased in all treatment groups, with LDH levels appearing highest in the cell group 
exposed to RID3 + 5 J/cm2 (p<0.472) and increased in cells treated at 10 J/cm2 (p<0.065) 
and 15 J/cm2 (p<0.174) (Figure 9).  
Figure 8: Cytotoxicity of CC cells after treatment with RI. Cells treated with RI30cH and D6 
demonstrated a slight decrease in LDH levels as compared to the control, whereas cells treated 
with RID3 demonstrated an increase in LDH (p<0.212). 
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Figure 9: Cytotoxicity of CC cells after treatment with a combination of RID3 and 680 nm laser. 
All combined treatment groups demonstrated an increase in LDH levels as compared to the 
control, with cells irradiated with RID3 + 5 J/cm2 demonstrating the highest increase in LDH 
respectively.  
4.2. Cell Death Analysis 
4.2.1. Annexin V/PI Staining  
Annexins are calcium-regulated proteins which bind to phospholipids and play a large 
role in the life cycle of cells with regards to apoptosis (Mirsaeidi et al., 2016). An Annexin 
kit makes use of fluorescent dye in order to detect the externalization of 
phosphatidylserine in cells which are apoptotic. Cells which are dead conjugate to 
propidium iodide (PI) which stains dead cells with a red fluorescence. Live cells show no 
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fluorescence (Invitrogen Catalogue V13242). Flow cytometers typically consist of a light 
source, an electronic network which detects various light signals at various intensities and 
a computer which records the results derived from the electronic detectors (Givan, 2001).  
The percentage of various cell populations were analysed using Annexin V/PI staining. 
The treatment groups studied in this experiment included the combination of RI (D3 
potency) with laser doses of 5, 10 and 15 J/cm2. Three fluencies of the 680 nm laser were 
used to find out the optimal fluency. Each treatment group was statistically analysed 
against the laser control group. These results have been summarised in Table 2. 
Cells treated with RID3 had a lower percentage of non-apoptotic cells (UL) (0.14%) 
compared to the control group (p<0.05). Surprisingly, the number of live cells (LL) was 
higher (74%) than the control group (p<0.01). There was a 21.36% of early apoptotic cells 
(LR) and 4.31% late apoptotic cells (UR). Cells exposed to a combination of R. idaeus 
D3 and 680 nm laser at 5 J/cm2 showed only 12% of UL as compared to the 20% of 
control cells. There was an increased number of LL in all three fluencies combined with 
RI D3 with 74.3%, 74.3 and 76.3 for RID3 +5, RID3+ 10 and RID3+ 15 J/cm2 as compared 
to the control (72%). The combined treatment groups showed lower percentage of early 
apoptotic cells (LR) such as RID3+ 5 J/cm2 (21.28%), RID3 +10 J/cm2 (20.78%) and 
RID3+ 15 J/cm2 (19.1%) compared to the control group (23.02%). Cells treated with RI 
D3+ 5J/cm2 (4.28%) and RID3 + 15 J/cm2 (4.32%) showed a slight increase in the number 
of late apoptotic cells. Cells treated with a combination of RID3+ 10J/cm2 (4.78%) 
demonstrated a large increase in the number of late apoptotic cells (p<0.001).  RID3 and 
680 nm at 15 J/cm2 produced the most statistically significant results out of the entire 
group, with p values of p<0.05 in UL, LL and LR. Combined treatment of RID3 and 680 
nm at a fluency of 10 J/cm2 produced the most statistically significant result in UR with a 
p value of <0.001. The dot plot graphical images of the results from the BD C- Sampler 
software can be found in Figure 10 and results are summarised in Table 2.  
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Table 2: Percentage of various cell populations after Annexin V/PI staining. The data depicted in 
the table was extracted by using the mean values of all percentages obtained from different 
treatment groups plus or minus the standard deviation (n=3). The lowest percentage of cellular 
apoptosis was obtained using the control and HeLa cells. (p<0.05 *; p<0.01**; p< 0.001 ***).  
Groups Upper Left (UL)- 
non-apoptotic  
Lower Left (LL)-
live Cells  
Lower Right  
(LR) - Early Apoptotic 
cells  
Upper Right (UR)- Late 
Apoptotic cells  
Control 0.20 ± 0.01 72.70 ± 0.57 23.02 ± 0,94 4.25 ± 0.06 
RID3 0.14 ± 2.88 ** 74.00 ± 0.58**  21.36 ± 0.09  4.31 ± 0.39 
RID3 + 5 J/cm2 0.12 ± 0.04  74.30 ± 0.33  21.28 ± 0.16 4.28 ± 0.05 
RID3 + 10 J/cm2 0.18 ± 0.03 74.30 ± 0.88  20.78 ± 0.95  4.78 ± 0.001 *** 
RID3 + 15 J/cm2 0.11 ± 0.02 * 76.30 ± 0.88 * 19.10 ± 0.96 * 4.32 ± 0.03 
 
 
 
 
 
 
 
 
 
Figure 10: Examples Annexin V/PI dot plots. One out of the three dot plots obtained per cell group 
are depicted in the above image. Fig. 10a) Untreated control cells demonstrating 74% viable cells 
with 4.4% late apoptotic cells, b) Cells treated with R. idaeus D3 demonstrating 73.3% live cells 
and 5% late apoptotic cells, c) RID3 + 15 J/cm2 demonstrating 78.1% live cells and 4.3% late 
apoptotic cells, d) RID3 + 10 J/cm2 demonstrating 74.8% live cells and 4.2% late apoptotic cells 
and e) RID3 + 75.9% demonstrating 75.9% live cells and 4.8% late apoptotic cells.  
4.2.2. Nuclear Damage Analysis Using Hoechst Staining  
The nuclear changes of cells treated with RID3 as well as cells treated with a combination 
of RID3 and 680 nm laser at doses of 5, 10 and 15 J/cm2 were compared to cells as 
shown in figure 10.  
P
I 
Annexin V 
a b c d e 
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In the control group, nuclei appeared spherical and evenly distributed. There were a large 
number of cells present in the sample which demonstrated good cellular viability. When 
analysing the group of cells treated with RID3, there appeared to be a significantly 
reduced number of cells which had been stained by the Hoechst dye which indicated a 
reduction in living cells. There also appeared to be irregularly shaped nuclei with more 
shrinked appearance as compared to those seen in the control group, which further 
confirmed the possibility of cellar death.  
With the combined treatment groups, the cells treated with RID3 and 680 nm laser at a 
dose of 5 J/cm2 showed a reduced number of viable cells as compared to the control 
group. There were no significant differences in the shape of the nuclei in this treatment 
group when compared to the control cells. Cells treated with RID3 and 680 nm at a dose 
of 10 J/cm2 showed a significant reduction in viable cells with few cellular nuclei which 
appeared to have a more rounded shape. The final treatment group of RID3 and 680 nm 
at a dose of 15 J/cm2 showed a slight decrease in cell number when compared to the 
control group. There was evidence of degrading nuclei seen with very low fluorescence 
uptake . Multiple nuclei showed a change in shape and became more rounded or shrinked 
in appearance as compared to the shape of the nuclei seen in the control group. The 
images obtained can be observed in Figure 11.  
 
Figure 11: Hoechst Staining of CC HeLa cells. Cytotoxic changes in CC HeLa cells were observed 
after 24 h of treatment with R. idaeus D3 and combined treatment of R. idaeus D3 and 680 nm 
laser diode (5, 10 and 15 J/cm2).  Fig 7a represents the control cells, (b) R. idaeus D3, (c) R. 
e d 
c a b  
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idaeus D3 + 5 J/cm2, (d) R. idaeus D3 + 10 J/cm2 and (e) R. idaeus D3 + 15 J/cm2. White arrows 
indicate dying cells with rounded/ shrinked nuclei.  
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CHAPTER 5.  
DISCUSSION 
5.1. Contextualising Cervical Cancer and the Research 
Study 
HPV rates are a cause for concern in Sub- Saharan Africa, with a minimum rate of 24% 
of women diagnosed with the infection annually. With this rise of HPV it is further a 
concern that CC rates will also increase due to the direct relationship between HPV 
strains 16 and 18, and the development of CC (Stewart et al., 2018; Williamson & Snyder, 
2015). Currently the treatments for CC possess numerous side effects, which cause 
discomfort in patients (Aredes et al., 2018). Both homeopathic medicine and LLLT have 
recently shown promise over the last few years, by inducing cell death and reducing 
cellular proliferation in cancer cells through various metabolic pathways (Bartos et al., 
2016) which interfere with cellular mitochondria, endoplasmic reticulum (Dewaele et al., 
2011) and various genes (Saha et al., 2013).  
Previous studies have shown an ability for R. idaeus in herbal preparations to possess 
high antioxidant content (De Souza, 2014) as well as an ability to improve absorption of 
chemotherapeutic drugs into cancer cells, further inducing apoptosis (Cho et al., 2016).  
The results observed in this study demonstrated antagonistic as well as complimentary 
results when compared to previous studies of a similar nature.  
5.2. Cellular Morphology 
Cellular morphology was observed by identifying the typical morphological features 
present in cellular apoptosis. Nuclear fragmentation, reduction in cell volume and 
chromatin condensation were considered in the evaluation (Kroemer et al., 2009).  
Morphological features of apoptosis were not present in cells treated with RI30cH and 
control cells. The cells were proliferating and were more confluent. When observing the 
morphological feature of RID6, there were several dead cells observed floating in the 
medium. The RID3 potency demonstrated the best results out of all the homeopathic 
preparations of RI. The morphological results demonstrated cellular shrinking and 
blebbing of CC in vitro, which are typical indications of cellular apoptosis.  
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Results obtained from the combined treatment were almost identical despite the fluence 
of laser used at this wavelength. The morphological changes which could be observed in 
the findings demonstrated no signs of blebbing in any of the groups of a combination of 
RID3 and 680 nm laser at doses of 5, 10 or 15 J/cm2. There were also no signs of loss of 
membrane integrity and cell structure changes with all cell groups demonstrating a good 
consistency.  
The low potency performance of RID3 goes against a previous study which made use of 
T. occidentalis, C. maculatum, Carcinosin and S. serrulata in potencies ranging from 
12cH to 1000cK in vitro and in vivo. This study found that none of the remedies had the 
ability to induce apoptosis of breast cancer cells in vitro or in vivo. The RI30cH results 
conflict with a study conducted by Samidha and colleagues (2017) which made use of 
remedies in a 30cH potency and observed the ability for this potency to induce apoptosis 
in melanoma (B16F10) cells.  
The laser results conflict with other research findings conducted by Allison et al. (2011) 
whereby laser had the ability to induce apoptosis in lung cancer cells at a wavelength of 
630 nm at a dose of 5 J/cm2. It is possible that the results obtained in this study conflict 
with Allison et al. (2011)’s findings due to the difference in wavelength used.  
More research needs to be conducted in order to investigate the mechanism behind these 
results  
5.3. Cellular Viability Using Trypan Blue Assay 
CC cells treated with RI30cH demonstrated an increased cellular viability of 82% 
(p<0.186) as compared to control cells which has a viability of 74%. This finding 
contradicts previous findings which made use of highly diluted homeopathic remedies in 
in vitro studies. One particular study made use of various remedies in dilutions of 200cH 
and 1000cH in the treatment of prostate cancer cells lines in vitro and observed a 
decrease in the number of viable cells (Jonas et al., 2006). Ruta graveolens 30cH 
demonstrated an ability to reduce colon cancer cell proliferation (Arora & Tandon, 2015).  
Homeopathic aggravations occur in cases whereby there is an initial worsening of 
symptoms which had existed at the time of administering the remedy. Aggravations are 
believed to occur to induce the body’s own healing potential by activating immune-system 
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cells. However, it is not possible for this to be the case in this study, as no immunological 
response could have occurred due to the in vitro nature of this study. 
CC cells treated with RID6 and D3 demonstrated a reduced cellular viability to 61% 
(p<0.283) and 59% (p<0.292) respectively. These findings correlate to previous studies 
which made use of low potencies of homeopathic remedies to induce apoptosis in cancer 
cells and increase cytotoxicity (Arora et al., 2013; Mondal et al., 2016; Arora et al., 2015).  
The combined treatment protocol also demonstrated a decreased cellular viability 60% in 
cells treated with a dose of RID3 + 5 J/cm2 (p<0.88), 53% in cells treated at a dose of 
RID3 +10 J/cm2 (p<0.41) and 59% in cells treated at a dose of RID3 + 15 J/cm2 (p<0.80). 
These results compliment results from previous studies whereby laser had the ability to 
reduce the viability of MCF-7 breast cancer cells at a dose of 15 J/cm2 (Horne et al., 
2012). These results also correlate with a previous study which demonstrated anti-
proliferative effects in prostate cancer cells at a dose of 5 J/cm2 with a wavelength of 670 
nm (Gheewala et al., 2018).  
5.4. Adenosine triphosphate (ATP) 
ATP is a nucleotide found in all living cells and its main function is to carry energy in cells. 
This nucleotide consists of three different structures; ribose, adenine and a triple-
phosphate chain (Augustyn et al., 2019). ATP has been used extensively as a means to 
measure cellular viability. When cells lose membrane integrity, the ability for them to 
synthesize ATP resulting in a decrease in ATP levels in cellular cytoplasm. The ATP 
assay is also considered one of the fastest means of measuring cellular viability (Riss et 
al., 2004).  
ATP levels increased in cells treated with RI30cH (p<0.945) and decreased in cells 
treated with RID3 (p<0.194). The increased ATP production after treatment with RI 30cH 
contradicts previously conducted studies which used highly diluted homeopathic 
remedies (Jonas et al., 2004; Torres et al., 2016; Noratto et al., 2016). One theory to this 
increase could be related to a promotion of cellular proliferation to improve CC cell 
viability. More research should be conducted in order to understand the mechanism 
behind this increase in ATP after treatment with RI30cH. RID6 demonstrated an increase 
in ATP suggesting the CC cell proliferation. The decreased ATP levels after the treatment 
with RID3 further relates to the blebbing observed in the morphological results, allowing 
  45 
for assumptions to be drawn towards the ability for this potency of RI to induce cell death 
in CC cells.  
CC cells treated with laser in combination with RID3 demonstrated an increase in ATP 
production at all doses of RID3 +5, RID3 +10 and RID3+ 15 J/cm2 (p<0.001, <0.01 and 
<0.001). As mentioned previously, LLLT possesses not only an anti-carcinogenic and 
pro- apoptotic function but also has the ability to induce photobiomodulatory effects; a 
process which is believed to induce photochemical reactions in cells in order to stimulate 
the healing of damaged cells (Chung & Dai, 2012). When photobiomodulation occurs, 
there is an increase in ATP levels due to the stimulation of the mitochondria of the cell 
(Chung et al., 2012). CC is also considered an aggressive form of cancer which utilizes 
glycolysis in order to produce high levels of ATP (Weinber & Chandel, 2015). This further 
relates to how a treatment protocol favours CC cell proliferation could result in an 
increased level of ATP. This finding further correlates to the morphological changes in 
CC cells.  
5.5. Lactate Dehydrogenase (LDH) 
LDH is an enzyme which is produced by metabolically active cells and is released into 
the medium when a cell loses its membrane integrity (Liu et al., 2016). LDH is considered 
an accurate means of establishing the number of dead cells present in the culture plate. 
This is due to the fact that LDH leaks out of cells into the medium when cells undergo 
apoptosis and loss of membrane integrity (Legrand et al., 1992). 
Both RI30cH (p<0.11) and RID6 (p<0.08) demonstrated a decrease in LDH levels. These 
findings in conjunction with the increase in ATP levels further confirm the favourable 
proliferative effect of these two potency preparations of RI on CC HeLa cells in vitro. LDH 
levels increased in cells treated with RID3 (p<0.212) which complimented the 
morphological results of blebbing and changes in membrane structure of the CC cells, 
decreased ATP levels and decreased cellular viability. This further enhances the 
proposed theory of the ability for RID3 to possibly induce apoptosis in CC cells.  
The cells treated with 680 nm laser combined with RID3 demonstrated a large decrease 
in LDH levels upon analysis at 5 (p<0.472), 10 (p<0.065) and 15 (p<0.174) J/cm2. These 
findings along with the findings of increased ATP and decreased viability are quite 
conflicting and go against the initial hypothesis that this particular wavelength of laser 
would increase cellular apoptosis in cancer cells when combined with RID3. However, 
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these results can be explained by making use of a phenomenon, observed in aggressive 
cancer cells, known as the Warburg effect.  
The Warburg effect refers to an increased uptake of glucose by cancer cells when in an 
optimal environment leading to an increase in the amount of LDH produced (Flores et al., 
2019) and is considered a major metabolic feature which exists in cancer cells (Zheng et 
al., 2018). A theory exists whereby LDH is considered a necessary acid in the proliferation 
of cancer cells. The reason behind this is that LDH is considered an important factor for 
angiogenesis and migration of cancer cells as well as the generation of Nicotinamide 
Adenine Dinucleotide (NAD+) (Husain et al., 2013; Bensinger & Christofk, 2012; Doherty 
& Cleveland, 2013).  
Research pertaining to the metabolic processes of CC has been conducted and 
demonstrated the oncogenic effects of microRNAs with the Warburg effect. MicroRNAs 
are considered to be responsible for the utilization of glucose in aerobic and anaerobic 
environments with LDH-A being the LDH responsible for an increase in CC cells 
proliferation (Zhang et al., 2016). With this knowledge, it can be hypothesized that the 
RID3 potency possibly interfered with cell cycle checkpoints in CC cells by interacting the 
5’- adenosine-monophosphate-activated protein kinase (AMPK) metabolic pathway 
(Marin- Aguilar et al., 2009). However, in the case of the combined treatment protocol of 
RID3 and the 680 nm laser, it can be theorised that an optimal environment was created 
for the CC cells to thrive and proliferate. This increased proliferation possibly resulted in 
an increased release of LDH-A, which was observed upon the LDH analysis. CC is 
considered an aggressive cancer which utilizes a process known as glycolysis in order to 
produce high ATP levels (Weinber & Chandel, 2015). This could further explain how a 
treatment protocol which favours CC proliferation could result in increased ATP levels.  
With an understanding of the various metabolic processes utilized by cancer cells and 
the need for substantial amounts of glucose for the glycolytic pathways, a further theory 
which could be deducted from the above-mentioned findings can be derived. Assuming 
that the decreased cellular viability observed in the viability results may be a result of the 
cells depleting their glucose stores in the media. This suggests that this particular 
wavelength should not be used in the treatment of CC cells and further research needs 
to be conducted in order to identify the best wavelength to induce apoptosis in CC cells.  
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5.6. Cell Death Analysis 
5.6.1. Annexin V/PI Staining 
Upon analysis of results obtained from the Annexin V/PI staining, it appeared that the 
results were conflicting when compared to other experimental analyses (ATP, LDH and 
Trypan blue).  
The most concerning results obtained were those pertaining to the untreated control cells. 
There were high levels of both Late and early apoptotic cells (4.25% and 23.02%) with 
only 72.7% viable cells. These results seemed to be closely related to other results 
obtained in cells treated with RID3 + 5, RID3 + 10 and RID3 + 15 J/cm2 which 
demonstrated 4.28%, 4.78% and 4.32% of late apoptotic cells and 21.28%, 20,78% and 
19,10% of early apoptotic cells. These results were conflicting when the high ATP levels 
and low LDH levels are taken into account from the previous analyses. Cells treated with 
a single treatment of RID3 demonstrated similar findings with 4.31% late apoptotic cells 
and 21.36% early apoptotic cells.  
Annexins are calcium-regulated proteins which bind to phospholipids (Mirsaeidi et al, 
2016). An Annexin kit makes use of fluorescent dye in order to detect the externalization 
of phosphatidylserine in cells, which is a measure of apoptosis in cells. Cells which are 
dead conjugate to propidium iodide (PI) which stains dead cells with a red fluorescence 
(Givan, 2001).  
It is reported that certain cell lines seem to have phosphatidylserine which exists naturally 
on the surface of cell membranes. This is particularly prominent in cell lines which are 
tumorigenic in nature (De et al., 2018). Phosphatidylserine typically exists on the internal 
membrane of cells due to aminophospholipidtranslocase (Kenis et al., 2009; Davis et al., 
2019). However, cancer cells lose the ability to translocate phosphatidylserine, resulting 
in its presence on the external surface of the cell membrane (Vallabhapurapu et al., 2015) 
without any signs of apoptosis ( De et al., 2018).. This is a result of an enzyme known as 
scramblase (Beck et al., 2006).  
With this, it can be theorized that the Annexin V and PI dyes bound to the naturally 
occurring externalized phosphatidylserine of the highly viable and apoptotic CC cells and 
this could be the reason why the Annexin V and PI results were conflicting when 
compared to other analyses. 
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It can further be suggested that further research into the use of Annexin V/PI staining in 
cancer cells lines with high expression of phosphatidylserine should be conducted in 
order to identify which cancer cell lines should not be assessed using flow- cytometry.  
5.6.2. Cell Death Results using Hoechst Staining 
Hoechst dye is considered as a very popular fluorophore used to stain the DNA of cells, 
as it has a specificity towards DNA (Bucevicius et al., 2018). Hoechst dyes are excited by 
a UV light or laser which emits a blue light with a maximum wavelength of 460 nm. An 
advantage of Hoechst dyes is that they do not induce cytotoxicity, allowing for objective 
results to be obtained when examining cell death (Watkins et al., 1996).  
Hoechst dye was used as a means of staining nuclei of CC cells in order to observe if 
any changes had occurred to the cellular nuclei after being treated with RID3 and a 
combination of LLLT 680 nm with RID3 at doses of 5, 10 and 15 J/cm2.  
Hoechst staining complimented other findings observed in ATP, LDH and viability assays. 
Cells treated with RID3 demonstrated a loss of nuclear integrity and a decreased number 
of viable cells as compared to untreated control cells. Cells treated with a combination of 
680 nm laser and RID3 at doses of 5, 10 and 15 J/cm2 demonstrated few changes with 
regards to shape and number when compared to the control cells. These findings further 
confirmed the theory that RID3 as a single treatment protocol has the ability to induce CC 
cell apoptosis whereas a combined treatment of RID3 and 680 nm laser enhances CC 
cell growth in vitro.  
The findings observed with RID3 compliment previous research studies which used lower 
potencies such as mother tinctures and 6cH. One such study found the ability for Ruta 
graveolens mother tincture to induce apoptosis in colon cancer cells by condensing the 
chromatin and releasing cytochrome c (Arora, 2015). The results obtained from RI30cH 
however conflict other research findings. Another study observed the ability for both 
Phosphorous and Arsenicum sulphuratum flavum in 30cH potencies to induce apoptosis 
in melanoma cancer cells (Samidha et al., 2017). 
No research has been conducted on a combination of 680 nm laser and RID3 or 
homeopathic remedies. Therefore more research needs to be conducted on the 
combined effects of homeopathic remedies and LLLT at a wavelength of 680 nm in order 
to further understand the mechanism behind these results.  
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CHAPTER 6.  
CONCLUSION  
6.1. Conclusion  
Cervical Cancer is one of the leading causes of death amongst women worldwide (Chen., 
et al, 2018). Conventional therapies currently used induce unfavourable side-effects in 
patients resulting in undesired discomfort. Recently, homeopathic medicine has become 
a popular form of therapy and has shown promise in previous in vitro studies to induce 
apoptosis in cancer cells. Low level laser therapy has also shown promise in its ability to 
induce apoptosis in cancer cells by targeting the mitochondria of cancer cells.  
This study aimed to investigate the use of Rubus idaeus in three homeopathic dilutions 
(30cH, D6 and D3) as a single treatment protocol and then in conjunction with 680 nm 
laser at doses of 5, 10 and 15 J/cm2.  
After the analysis of the results obtained from this study, there is an indication that R. 
idaeus D3 can initiate apoptosis of CC HeLa cells in vitro in the following respects; 
morphological changes depicted a fewer number of live cells as compared to untreated 
cells, decreased percentage of viable cells (59%), a decrease in ATP levels, increase in 
LDH levels, and nuclear and cellular changes typical of cells undergoing apoptosis 
(blebbing and shrinking) were evident from Hoechst staining. These results may indicate 
the beneficial effect of this homeopathic preparation of CC in vitro. The results could be 
more evident in an in vivo model.  
Further results established indicated the ability of R. idaeus 30cH to accelerate CC HeLa 
cell growth in the following respects; little changes were observed upon cellular 
morphology, significantly increased percentage of viable cells (82%) with an increase in 
ATP levels and decrease in LDH levels. This suggests that this potency of R. idaeus 
should be avoided in patients with CC.  
The combined treatment protocol of R. idaeus D3 with the 680 nm demonstrated an ability 
to activate the Warburg effect which is seen in highly viable tumorigenic cancer cells. This 
conclusion was drawn after careful analysis of the results obtained, demonstrating an 
increase in both LDH and ATP levels in cells treated with Rubus idaeus and 680 nm laser 
at all three doses of 5, 10 and 15 J/cm2. This further denotes that the 680 nm laser 
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wavelength in combination with R. idaeus D3 is an unfavourable combination treatment 
for cervical cancer.  
It is advisable that further in vitro and in vivo studies be conducted in order for a conclusion 
to be drawn with regards to the exact mechanisms of action of R. idaeus D3 on CC HeLa 
cells and a combination of homeopathic remedies and LLLT. This research further 
exemplifies that homeopathically prepared solutions cannot be regarded as placebo. 
6.1.1. Future Perspectives  
 Experiments were conducted 24 h after the treatment with homeopathically 
prepared R. idaeus and a combination of R. idaeus D3 and 680 nm laser. This 
could be a plausible explanation behind why certain results were insignificant in 
nature. It is recommended that future studies conduct experiments at various time 
lapses in order to observe if any changes in results occur. 
 Further research into the investigation of which cancer cell lines exhibit higher 
levels of phosphatidylserine on the cell membrane should be conducted with 
careful consideration into which cell death analyses should be used for future 
research.  
 Further research into the use of combined treatment protocols of homeopathic 
medicine and LLLT should be conducted to develop novel CC treatment strategies.  
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APPENDIX A 
Methodology Flow Diagram  
 
 
 
Cellular Response Assays after 24 hours
Morphology: inverted light microscope
Viability: Trypan Blue
Cytotoxicity: LDH
Proliferation: ATP
Cell Death Analysis
Apoptosis: Annexin V/PI Staining
Nuclear Damage: Hoechst Stain
Cell Treatment Groups
Group 1
Untreated Control Cells
Group 2
Rubus idaeus (30cH, D6 
and D3)
Group 3
Optimal potency of R. 
idaeus and 680 nm laser (5, 
10 and 15 J/cm2)
Cervical Cancer HeLa Cells (CCL-2)
Cultured at 37oC with 5% CO2 and 80% humidity
The in vitro Effects of Homeopathically Prepared Rubus idaeus
and Low Level Laser Therapy on Cervical Cancer Cells
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APPENDIX B 
List of Media and Solutions Used 
HeLa Cell (ATCC CCL-2) culture  media 
Dulbecco’s Modified Eagle 
Medium (DMEM) 10 % complete 
cell growth medium 50 mL 
DMEM 44.0 mL 
FBS 5 mL 
Penicillin-streptomycin 0.5 mL 
Amphotericin 0.5 mL 
Dulbecco’s Modified Eagle 
Medium (DMEM) 20% complete 
cell growth medium 50 mL 
DMEM 39.0 mL 
FBS 10 mL 
Penicillin-streptomycin 0.5 mL 
Amphotericin 0.5 mL 
 0.01 M PBS 1.25 mL 
Products used for the Process of Sterilization 
70% Ethanol Absolute ethanol 70 mL 
Autoclaved distilled water 30 mL 
Products used for Experiments Conducted 
1x Annexin V-FITC/PI 10x binding buffer 1.7 mL 
Autoclaved distilled water 17 mL 
Powdered Propidium Iodide 250 mg 
1x binding buffer 1 mL 
ATP Cell Titre-Glo reagent ATP Cell Titre-Glo buffer 1 mL 
ATP Cell Titre-Glo substrate 0.007 g 
LDH reconstitute LDH assay buffer 1.2 mL 
LDH substrate mix 0.012 g 
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10 mg/mL Hoechst stock Powdered Hoechst 0.001 g 
Autoclaved distilled water 1 mL 
4% Paraformaldehyde solution Paraformaldehyde powder 40 g 
0.01 M PBS 1 L 
0.01 M PBS Phosphate buffered saline powder 1 packet 
Autoclaved distilled water 1 L 
Autoclaved distilled water 99.5 mL 
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APPENDIX C 
List of Equipment Used for Irradiation, Morphological 
Analysis and Cell Counting of HeLa (CCL-2) Cells.  
Product name Catalogue number Supplier/Manufacturer 
680 nm Laser Oriel Corporation, USA, 
LREBT00-ROITHI 
National Laser 
Centre 
Power Meter Field Mate 125JO7R National Laser 
Centre 
Light Microscope Olympus CKX41 Wirsam 
Fluorescent Microscope Axio observer Z1 Carl Zeiss 
Countess Automated 
Cell Counter 
C10227 Invitrogen 
Flow Cytometer BD Accuri™ C6 Cytometer  
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APPENDIX D 
List of Chemicals and Kits Used  
Name of Chemical/ Kit 
used 
Product Catalogue 
Number 
Name of Supplier 
or Company 
Amphotericin B A2942 Sigma Aldrich 
Annexin V/PI 
apoptosis detection kit 
556570 BD PharmingenTM 
Biofreezing medium 25 
mL 
F2270 Biochrom AG 
Cell culture dish 35 
mm × 10 mm 
430165 Corning 
Cell Titer-Glo® ATP 
kits 
G7570 Promega 
Centrifuge tube, 50 
mL, 
PP flat top, sterile, 
bulk 
CR430829 Corning 
Coverslips CG88 Lasec 
Cryogenic vial, Int-
thread, 2 mL, round 
CR430489 Corning 
CytoTox 96® Non-
Radioactive 
Cytotoxicity Assay 
G1780 Promega 
Dimethyl sulfoxide (50 
mL) 
D8418 Sigma Aldrich 
Disposable pipette (1 
mL) 
BD357522 Becton Dickinson 
Disposable pipette (2 
mL) 
BD357507 Becton Dickinson 
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Disposable pipette (5 
mL) 
BD357543 Becton Dickinson 
Disposable pipette
 (10 mL) 
BD357551 Becton Dickinson 
Dulbecco’s Modified 
Eagle’s Medium 
D5796 Sigma Aldrich 
Eppendorf®, 
Microtubes 
Z666521 Sigma Aldrich 
Eppendorf®, 
Microtubes 
Z666505 Sigma Aldrich 
Eppendorf®, 
Microtubes 
Z666515 Sigma Aldrich 
Falcon (5mL) 
Polystyrene round 
bottom tube (flow 
cytometry tubes) 
BD352054 Beton Dickinson 
Foetal Bovine Serum 10499-044 Thermo Fisher 
Scientific 
Hanks Balances Salt 
Solution 
H9394 Sigma Aldrich 
Heavy tin foil 5 m × 45 
cm 
6001007162603 Pick n’ Pay 
Hoechst 33258  
Pentahydrate (bis-
benzimide) 10 mg 
H1398 Invitrogen 
molecular probe 
Latex gloves small 
powder free 
EV/40511 Scientific group 
HeLa cell line ATCC: CCL-2 ATCC 
Microplate, 96 well, F- 
Botton clear, sterile 
2pcs/bag 
655161 Sigma Aldrich 
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Microplate, 96 well, F-
Botton (Chimney well), 
white, lumitrac, high 
binding, sterile 
10pcs/bag 
655074 Sigma Aldrich 
Penicillin-
Streptomycin 
P4333 Sigma Aldrich 
Tissue culture 
flask 25 cm2, 
angled neck, 
vent, sterile 
CR/423052 Corning 
Tissue culture flask 75 
cm2, canted neck, anti-
tip, vent, sterile 
CR/430641U Corning 
Tissue culture 
flask 175 cm2, 
canted neck, 
vent, sterile 
CR/431080 Corning 
Trypan Blue T8154 Sigma Aldrich 
Universal fit pipette 
tips,100-1000 µL Bulk 
CR4868 Corning 
Rubus idaeus 30cH, 
D6 and D3 30 ml 
Amber Glass Bottle 
Fusion Homeopathics  
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APPENDIX E 
Outline on the calculations conducted in order to create 
various potencies of R. idaeus 
Decimal Ratio Mathematical Formula to produce R. idaeus 20 ml of D3 
and 20 ml of D6  
3/10 x 10 = 3 mL of mother tincture 
10 mL – 3 mL = 7 mL 62% 
3 mL of mother tincture will then be added to 7 mL of 62% EtOH to make Rubus idaeus 
D1. 
1/10 x 10 = 1 mL of Rubus idaeus D1 
10 mL- 1 mL = 9 mL of distilled water 
Therefore, 1 mL of Rubus idaeus D1 will be added to 9 mL of distilled water. 
Remedy will then be succussed 10 times in order to create Rubus idaeus D2.  
1/10 x 20 = 2 mL of Rubus idaeus D2 
20 mL – 2 mL = 18 mL of Distilled water  
Therefore, to create Rubus idaeus D3, 2 mL of D2 will be added to 18 mL of distilled 
water and succussed 10 times.  
 Further dilutions following the same process as above, will be done until a D5 
potency has been achieved.  
In order to create 20 mL of Rubus idaeus D6:  
1/10 x 20 mL = 2 mL of Rubus Idaeus D5  
20 mL – 2 mL = 18 mL of distilled water 
Therefore 2 mL of Rubus idaeus D5 will be added to 18 mL of distilled water  
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This will then be succussed 10 times in order to create the final product of 20 mL of Rubus 
idaeus D6 
Centesimal Mathematical Formula for the production of R. idaeus 30cH 
Mathematical Formula for the Calculation of Amount of R. idaeus Mother Tincture 
Needed to Make 10 mL of Rubus idaeus 1cH: 
3/100 x 10 = 0.3 mL of mother tincture 
10-0.3 mL = 9.7 mL of 62% alcohol 
0.3 mL of R. idaeus mother tincture will be added to 9.7 mL of 62% EtOH to make Rubus 
idaeus 1cH 
1/100 x 10 = 0.1 mL of Rubus idaeus 1cH 
10 mL – 0.1 mL = 9.9 mL of distilled water 
Therefore, 0.1 mL of Rubus idaeus 1cH will be added to 9.9 mL of distilled water 
Remedy will then be succussed 100 times in order to create Rubus Idaeus 2cH 
This process will be repeated until a 29cH potency has been created. 
In order to create 20 mL of Rubus idaeus 30cH:  
1/100 x 20 mL = 0.2 mL of Rubus Idaeus 29cH  
20 mL – 0.2 mL = 19.8 mL of distilled water 
Therefore 0.2 mL of Rubus idaeus 29cH will be added to 18 mL of distilled water  
This will then be succussed 100 times in order to create the final product of 20 mL of 
Rubus idaeus 30cH 
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APPENDIX F 
Laser Parameters Used in This Study  
a) Parameters for Cells irradiated with a Combination of r. idaeus D3 
and LLLT 680 nm for ATP, LDH and ATP Assay Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Manufacturer Oriel Corporation 
Name and Type Diode Semiconductor Laser 
Wavelength 680 nm 
Spectrum Visible (Red) 
Wave Emission Continuous 
Spot Size 9.1 cm2 
Power Output 201 mW 
Power Density 22.15 mW/cm2 
Fluence and 
Irradiation time 
5 J/cm2 (3 min 47 sec) 
 10 J/cm2 (7 min 34 sec) 
 15 J/cm2 (11 min 22 sec) 
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b) Parameters for Cells Irradiated with a Combination of R. idaeus 
D3 and LLLT 680 nm for Cytotoxicity Assays 
Manufacturer Oriel Corporation 
Name and Type Diode Semiconductor Laser 
Wavelength 680 nm 
Spectrum Visible (Red) 
Wave Emission Continuous 
Spot Size 9.1 cm2 
Power Output 205 mW 
Power Density 22.59 mW/cm2 
Fluence and 
Irradiation time 
5 J/cm2 (3 min 37 sec) 
 10 J/cm2 (7 min 14 sec) 
 15 J/cm2 (10 min 52 sec) 
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APPENDIX G 
Laser Calculations 
The power output of the 680 nm laser diode was measured before treatment by using a 
laser power meter which measures in mW. The energy of the laser decreases as the light 
moves through air. The dosage of each treatment was expressed as J/cm2, with fluencies 
delivered at 5, 10 and 15 J/cm2. 
The below image demonstrates the formulae used for the laser calculations:  
 
Calculation for first cell group irradiated for viability, morphology, ATP 
and LDH experiments:  
(201mW x 4)/ (3.14 x 3.42) = 22.15mW/cm2 
22.15mW/ 1000= 0.022 W/cm2 
Dose= 0.022 x time (s) 
5 J/cm2 
Time (s)= 5 J/cm2/ 0.022 
              = 227.27 sec 
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              = 227.27 / 60 
              = 3. 787833333333333  
= 3 min 
3. 787833333333333 – 3 
= 0. 787833333333333 
0. 787833333333333 x 60 
= 47 sec 
Therefore for an energy of 5 J/cm2 cells must be irradiated for 3 min 47 sec.  
10 J/cm2 
Time (s) = 10 J/cm2/ 0.022 
              = 454.55 sec 
              = 454.55 / 60 
              = 7,575833333333333 
= 7 min 
7,575833333333333 – 7 
= 0,575833333333333 
0,575833333333333x 60 
= 34 sec 
Therefore, for an energy of 10 J/cm2 cells must be irradiated for 7 min 34 sec.  
15 J/cm2 
Time (s) = 15 J/cm2/ 0.022 
              = 681.82 sec 
  77 
              = 681.82 / 60 
              = 11,36366666666667 
= 11 min 
11,36366666666667– 11 
= 0,36366666666667 
0,36366666666667x 60 
= 22 sec 
Therefore, for an energy of 15 J/cm2 cells must be irradiated for 11 min 22 sec.  
Calculation for second cell group irradiated for Hoechst staining and 
Annexin V/PI staining experiments 
(205 mW x 4)/ (3.14 x 3.42) =22.59 mW/cm2 
22.59 mW/ 1000= 0.023 W/cm2 
Dose= 0.023 x time (s) 
5 J/cm2 
Time (s) = 5 J/cm2/ 0.023 
              = 217.39 sec 
              = 217.39 / 60 
              = 3,623166666666667 
= 3 min 
3,623166666666667– 3 
= 0,623166666666667 
0,623166666666667x 60 
= 37 sec 
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Therefore, for an energy of 5 J/cm2 cells must be irradiated for 3 min 37 sec.  
10 J/cm2 
Time (s) = 10 J/cm2/ 0.023 
              = 434.78 sec 
              = 434.78 / 60 
              = 7,246333333333333 
= 7 min 
7,246333333333333– 7 
= 0,246333333333333 
0,246333333333333x 60 
= 14 sec 
Therefore, for an energy of 10 J/cm2 cells must be irradiated for 7 min 14 sec.  
15 J/cm2 
Time (s) = 15 J/cm2/ 0.023 
              = 652.17 sec 
              = 652.17 / 60 
              = 10,8695 
= 10 min 
10,8695– 10 
= 0,8695 
0,8695 x 60 
= 52 sec 
Therefore, for an energy of 15 J/cm2 cells must be irradiated for 10 min 52 sec.  
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APPENDIX H 
HeLa Cells (ATCC CCL-2) Product Information 
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APPENDIX I 
HeLa Cells (ATCC CCL-2) Certificate of Analysis 
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APPENDIX J 
ATCC Laboratory Biosafety Clearance 
 
-----Original Message----- 
From: ATCC Sales [mailto:Sales@atcc.org]  
Sent: 14 September 2010 10:46 PM 
To: Houreld, Nicolette <nhoureld@uj.ac.za>; Abrahamse, Heidi 
<habrahamse@uj.ac.za> 
Subject: ATCC Accounts LKS: BSL2 Upgrade Complete/184983 
 
 
Good Afternoon, 
 
This is to confirm that your request to have Cnr Siemert & Beit Streets be able to receive 
BSL-2 materials, has been approved and completed. Your order has been sent for 
processing. If we can be of further assistance please don't hesitate to contact us. 
 
Regards, 
 
Lauren 
New Accounts 
sales@atcc.org 
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APPENDIX K 
Research Ethics Committee Clearance Renewal Letter 
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APPENDIX L 
Higher Degrees Committee Approval Letter 
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APPENDIX M 
Turnitin Plagiarism Report 
 
 
